Drug Industry: That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.Industry: Any enterprise centered on the processing, assembly, production, or marketing of a line of products, services, commodities, or merchandise, in a particular field often named after its principal product. Examples include the automobile, fishing, music, publishing, insurance, and textile industries.Tobacco Industry: The aggregate business enterprise of agriculture, manufacture, and distribution related to tobacco and tobacco-derived products.Food Industry: The industry concerned with processing, preparing, preserving, distributing, and serving of foods and beverages.CaliforniaMarketing: Activity involved in transfer of goods from producer to consumer or in the exchange of services.Academic Medical Centers: Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc.Marketing of Health Services: Application of marketing principles and techniques to maximize the use of health care resources.Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.Universities: Educational institutions providing facilities for teaching and research and authorized to grant academic degrees.Ethics, Medical: The principles of professional conduct concerning the rights and duties of the physician, relations with patients and fellow practitioners, as well as actions of the physician in patient care and interpersonal relations with patient families.Ethics: The philosophy or code pertaining to what is ideal in human character and conduct. Also, the field of study dealing with the principles of morality.Scientific Misconduct: Intentional falsification of scientific data by presentation of fraudulent or incomplete or uncorroborated findings as scientific fact.Heparin, Low-Molecular-Weight: Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.Anticoagulants: Agents that prevent clotting.Heparin: A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.Enoxaparin: Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)Nadroparin: A heparin fraction with a mean molecular weight of 4500 daltons. It is isolated from porcine mucosal heparin and used as an antithrombotic agent. (From Merck Index, 11th ed)Hemorrhage: Bleeding or escape of blood from a vessel.Legislation, Drug: Laws concerned with manufacturing, dispensing, and marketing of drugs.Chewing Gum: A preparation of chicle, sometimes mixed with other plastic substances, sweetened and flavored. It is masticated usually for pleasure as a candy substitute but it sometimes acts as a vehicle for the administration of medication.Tobacco: A plant genus of the family SOLANACEAE. Members contain NICOTINE and other biologically active chemicals; its dried leaves are used for SMOKING.Lobbying: A process whereby representatives of a particular interest group attempt to influence governmental decision makers to accept the policy desires of the lobbying organization.Supreme Court Decisions: Decisions made by the United States Supreme Court.Drugs, Generic: Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.Civil Rights: Legal guarantee protecting the individual from attack on personal liberties, right to fair trial, right to vote, and freedom from discrimination on the basis of race, color, religion, sex, age, disability, or national origin. (from http://www.usccr.gov/ accessed 1/31/2003)IndiaJurisprudence: The science or philosophy of law. Also, the application of the principles of law and justice to health and medicine.United StatesResearch Report: Detailed account or statement or formal record of data resulting from empirical inquiry.Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.Foundations: Organizations established by endowments with provision for future maintenance.Dietetics: The application of nutritional principles to regulation of the diet and feeding persons or groups of persons.EuropeUnited States Department of Agriculture: A cabinet department in the Executive Branch of the United States Government concerned with improving and maintaining farm income and developing and expanding markets for agricultural products. Through inspection and grading services it safeguards and insures standards of quality in food supply and production.Biotechnology: Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction.Drug Discovery: The process of finding chemicals for potential therapeutic use.Life Expectancy: Based on known statistical data, the number of years which any person of a given age may reasonably expected to live.Animal Husbandry: The science of breeding, feeding and care of domestic animals; includes housing and nutrition.Value-Based Purchasing: Purchasers are provided information on the quality of health care, including patient outcomes and health status, with data on the dollar outlays going towards health. The focus is on managing the use of the health care system to reduce inappropriate care and to identify and reward the best-performing providers. (from http://www.ahrq.gov/qual/meyerrpt.htm accessed 11/25/2011)Pharmaceutical Preparations: Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.Social Control, Formal: Control which is exerted by the more stable organizations of society, such as established institutions and the law. They are ordinarily embodied in definite codes, usually written.Medical Waste Disposal: Management, removal, and elimination of biologic, infectious, pathologic, and dental waste. The concept includes blood, mucus, tissue removed at surgery or autopsy, soiled surgical dressings, and other materials requiring special control and handling. Disposal may take place where the waste is generated or elsewhere.Alcohol Drinking: Behaviors associated with the ingesting of alcoholic beverages, including social drinking.Voice: The sounds produced by humans by the passage of air through the LARYNX and over the VOCAL CORDS, and then modified by the resonance organs, the NASOPHARYNX, and the MOUTH.Administrative Personnel: Individuals responsible for the development of policy and supervision of the execution of plans and functional operations.Alcohols: Alkyl compounds containing a hydroxyl group. They are classified according to relation of the carbon atom: primary alcohols, R-CH2OH; secondary alcohols, R2-CHOH; tertiary alcohols, R3-COH. (From Grant & Hackh's Chemical Dictionary, 5th ed)Journalism, Medical: The collection, writing, and editing of current interest material on topics related to biomedicine for presentation through the mass media, including newspapers, magazines, radio, or television, usually for a public audience such as health care consumers.Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.Commerce: The interchange of goods or commodities, especially on a large scale, between different countries or between populations within the same country. It includes trade (the buying, selling, or exchanging of commodities, whether wholesale or retail) and business (the purchase and sale of goods to make a profit). (From Random House Unabridged Dictionary, 2d ed, p411, p2005 & p283)Hepacivirus: A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species.Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Revolving drug funds: a step towards health security. (1/1252)

The establishment of a revolving drug fund project in Viet Nam is described and the factors responsible for its success are considered. As well as being a tool for cost recovery a revolving drug fund can serve as an entry point for strengthening health care and improving health security at local and district level.  (+info)

Sales practices of patent medicine sellers in Nigeria. (2/1252)

A survey was carried out among patent medicine dealers to evaluate their practices that militate against laws governing prescriptions-only medicines in Nigeria. Questionnaires were distributed to 46 patent medicine dealers and later collected from them on appointment. Analysis of the results showed that all the patent medicine dealers were aware of the law governing the sale of prescription drugs in Nigeria. Seventy-five per cent of them stock such drugs. Patent medicine dealers obtain their drugs largely from sales representative of pharmaceutical companies as well as from industries. Inappropriate use of sales boys and girls in patent medicine stores and defective government policies were all investigated.  (+info)

Hospitals and managed care: catching up with the networks. (3/1252)

Although the growth of managed care is having a significant impact on hospitals, organizational response to managed care remains fragmented. We conducted a survey of 83 hospitals nationwide that indicated that most hospitals now have at least one person devoted to managed care initiatives. These individuals, however, often spend most of their time on current issues, such as contracting with managed care organizations and physician relations. Concerns for the future, such as network development and marketing, although important, receive less immediate attention form these individuals. Hospital managed care executives must take a more proactive role in long range managed care planning by collaborating with managed care organizations and pharmaceutical companies.  (+info)

The challenge of integrating monoclonal antibodies into the current healthcare system. (4/1252)

Although there are few monoclonal antibody (MoAb) products on the market, the biotechnology industry has made considerable progress over the last decade. The industry has developed new technology to address the primary hurdles facing the development of MoAbs--including the immune response to murine-derived antibodies as well as lack of tumor specificity. As the techniques for development become more refined, more products will be approved by the Food and Drug Administration. Integrating these products into the existing healthcare system will be a challenge, given their high acquisition costs. Recent pharmacoeconomic examples outlined in this paper confirm that MoAb products will need to be supported with proven clinical and economic profiles. As long as a global clinical and economic perspective is taken and patient care benefits can be demonstrated, the place of MoAbs in the future of healthcare will be assured.  (+info)

Sale of drugs and health care utilization in a health care district in Zaire. (5/1252)

Health centres of Idjwi district (Zaire) have been self-financed through the selling of drugs since 1985. Medical care is expensive and its use is low (24 visits per year per 100 inhabitants). In 1989 the medical team tried to reduce the cost of visits by changing the prices of drugs and prescriptions. A limited control was set up to assess this intervention. The study showed that although prescribed drug costs were stabilized compared to inflation, there was no increase in the use of medical care. Moreover, the reduction of drug profit margins for health centres seriously affected the health care institution by causing a drop in income. Six months after the intervention the monthly accounts showed a deficit in 6 centres out of 8. The need for health care centres to be self-financing is a major limiting factor in the use of health care in Idjwi district. There are no easy solutions for health centre managers that satisfy both low-cost access to care and health care self-financing. Some minimal financial participation from the state is required. Only then can the concept of financing health care through the selling of drugs be operational.  (+info)

Managed care guidelines for the economic evaluation of pharmaceuticals. (6/1252)

Foundation Health Corporation, through its National Pharmacy and Therapeutics Committee, requires all pharmaceutical manufacturers and others who wish products to be considered for formulary listing to meet evidentiary and analytical standards in their submission documentation. This article details the evidentiary and analytical standards required from those making submissions and describes the methodological basis of the guidelines. This is the first time, as far as the authors are aware, that a managed care health system in the United States has required formulary submissions not only to meet clinical and economic evaluation standards, but also to take explicit account of the perspective of the managed care group in applying these techniques. Submissions are required to take what is described as a systems impact perspective. This approach is quite different, in both evidentiary and analytical terms, from standards required by health systems in other countries and standards for the economic evaluation of pharmaceuticals proposed by expert groups in the United States.  (+info)

Three countries' experience with Norplant introduction. (7/1252)

Despite international efforts to plan for Norplant introduction, the method has drawn the attention of critics of family planning programmes, and has raised several issues for debate since it was introduced into family planning programmes. The experiences of three countries with the introduction of Norplant highlight some of the unique features of the method that have affected its introduction. Indonesia, Bangladesh and the United States represent diverse cultural settings and systems of family planning provision. Experience in each country has highlighted the need to focus on quality of care for clients, most notably the need for good counselling and attention to removal as well as insertion. The cost of Norplant also has influenced its introduction in each country. Another issue includes the need to work with women's health advocacy groups, which is illustrated particularly in Bangladesh. Finally, the role of litigation in the United States, and its potential role in influencing Norplant introduction in other countries, is discussed. These three countries' experience illustrate the importance of understanding the programmatic context of contraceptive introduction.  (+info)

Outcomes research: collaboration among academic researchers, managed care organizations, and pharmaceutical manufacturers. (8/1252)

Medical and pharmaceutical outcomes research has been of increasing interest in the past 10 to 15 years among healthcare providers, payers, and regulatory agencies. Outcomes research has become a multidisciplinary field involving clinicians, health services researchers, epidemiologists, psychometricians, statisticians, psychologists, sociologists, economists, and ethicists. Collaboration among researchers in different organizations that offer different types of services and various research expertise is the essential element for any successful outcomes project. In this article we discuss collaboration on outcomes research among academic researchers (mainly those who work in colleges of pharmacy), managed care organizations, and research-based pharmaceutical manufacturers, with a focus on the opportunities and challenges facing each party. The pharmaceutical industry needs information to make product and promotion decisions; the managed care industry has data to offer but needs analysis of these data; and pharmacy schools, among other academic institutions, have skilled researchers and data-processing capacity but require projects for revenue, research training, experience, and publications. Challenges do exist with such endeavors, but collaboration could be beneficial in satisfying the needs of the individual parties.  (+info)

New Jersey Flexible Pharmaceutical Sales Representative jobs, New Jersey Flexible Pharmaceutical Sales Representative careers, New Jersey Flexible Pharmaceutical Sales Representative job, New Jersey Flexible Pharmaceutical Sales Representative career, New Jersey Flexible Pharmaceutical Sales Representative employment, New Jersey Flexible Pharmaceutical Sales Representative work, New Jersey Flexible Pharmaceutical Sales Representative job opportunities, New Jersey Flexible Pharmaceutical Sales Representative employment opportunities, Flexible Pharmaceutical Sales Representative jobs in New Jersey, Flexible Pharmaceutical Sales Representative careers in New Jersey
Search Pharmaceutical Sales Representative jobs in Orlando, FL with company ratings & salaries. 370 open jobs for Pharmaceutical Sales Representative in Orlando.
Hawaii Direct Sales Representative jobs, Hawaii Direct Sales Representative careers, Hawaii Direct Sales Representative job, Hawaii Direct Sales Representative career, Hawaii Direct Sales Representative employment, Hawaii Direct Sales Representative work, Hawaii Direct Sales Representative job opportunities, Hawaii Direct Sales Representative employment opportunities, Direct Sales Representative jobs in Hawaii, Direct Sales Representative careers in Hawaii
100 Pharmaceutical Sales Representative $50,000 jobs available in Philadelphia, PA on Indeed.com. Field Sales Representative, Sales Professional, Sales Representative and more!
Headline: Bitcoin & Blockchain Searches Exceed Trump! Blockchain Stocks Are Next!. Antiemetic Drugs Industry is expected to witness growth of international market with respect to advancements and innovations including development history, competitive analysis and regional development forecast.. The report starts with a basic Antiemetic Drugs Industry overview. In this introductory section, the research report incorporates analysis of definitions, classifications, applications and industry chain structure. Besides this, the report also consists of development trends, competitive landscape analysis, and key regions development status.. The Antiemetic Drugs Industry research report shed light on Foremost Regions like:. North America, Europe, China, Japan, Southeast Asia and India. Application likes Chemotherapy, Pregnancy, Motion Sickness, Food Poisoning, Gastroenteritis and Diziness. Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in Antiemetic Drugs Industry Research [email protected] ...
61 Pharmaceutical Sales Representative jobs available in Colorado on Indeed.com. Sales Representative, Sales Professional, Program Manager and more!
Table 1: Pharmaceutical Market, Canada, Revenue ($bn), 2009-2016 Table 2: Pharmaceutical Market, Canada, Revenue Forecast ($bn), 2017-2021 Table 3: Pharmaceutical Market, Canada, Pharmaceutical Spending (% of health spending), 2009-2015 Table 4: Pharmaceutical Market, Canada, Pharmaceutical Exports and Imports ($bn), 2009-2016 Table 5: Pharmaceutical Market, Canada, Average Price Generic Drug vs. Branded Drug, 2009-2016 Table 6: Pharmaceutical Market, Biologics, Canada, Approved Biologics, 2016 Table 7: Pharmaceutical Market, Canada, Over-the-Counter Drug Market Revenue ($bn), 2009-2016 Table 8: Pharmaceutical Market, Canada, Sales of Patented Drug Products by Major Therapeutic Class ($bn), 2015 Table 9: Pharmaceutical Market, Canada, Major Drug Classes by Annual Growth Rate (%), 2012-2015 Table 10: Pharmaceutical Market, Johnson & Johnson, Canada, Major Products, 2016 Table 11: Pharmaceutical Market, Johnson & Johnson, Planned Filings, 2017-2020 Table 12: Pharmaceutical Market, Novartis, ...
Additionally, type wise and application wise consumption figures are also given. With the help of supply and consumption data, gap between these two is also explained.. To provide information on competitive landscape, this report includes detailed profiles of Nano Pharmaceutical Market key players. For each player, product details, capacity, price, cost, gross and revenue numbers are given. Their contact information is provided for better understanding.. In Nano Pharmaceutical Market report analysis, traders and distributors analysis is given along with contact details. For material and equipment suppliers also, contact details are given. New investment feasibility analysis and Nano Pharmaceutical Market Industry growth is included in the report.. No. of Report Pages: 124. Price of Report (Single User Licence): $2900. Purchase Nano Pharmaceutical Market Report at: http://www.360marketupdates.com/purchase/10417531. About 360 Market Updates:. 360 Market Updates is an upscale platform to help key ...
anti drug manufacturer/supplier, China anti drug manufacturer & factory list, find qualified Chinese anti drug manufacturers, suppliers, factories, exporters & wholesalers quickly on Made-in-China.com.
PHARMACEUTICAL MARKET INDIA 2014-2020 : Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, - Market research report and industry analysis - 8283773
Read on to discover how you can exploit the future business opportunities emerging in this sector.. In this brand new report you find 181-page report you will receive 107 charts - all unavailable elsewhere.. The 181-page report provides clear detailed insight into the Brazilian Pharmaceutical market. Discover the key drivers and challenges affecting the market.. By ordering and reading our brand new report today you stay better informed and ready to act.. Report Scope. • Brazilian Pharmaceutical Market forecasts from 2017-2027. • Brazilian Pharmaceutical Market forecasts from 2017-2027, by segment ...
Read on to discover how you can exploit the future business opportunities emerging in this sector.. In this brand new report you find 181-page report you will receive 107 charts - all unavailable elsewhere.. The 181-page report provides clear detailed insight into the Brazilian Pharmaceutical market. Discover the key drivers and challenges affecting the market.. By ordering and reading our brand new report today you stay better informed and ready to act.. Report Scope. • Brazilian Pharmaceutical Market forecasts from 2017-2027. • Brazilian Pharmaceutical Market forecasts from 2017-2027, by segment ...
2015 Global Neurodegenerative Diseases Drug Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Neurodegenerative Diseases Drug industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).. The report firstly introduced the Neurodegenerative Diseases Drug basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Neurodegenerative Diseases Drug ...
List of Figures Figure Picture of Acne Drugs Figure Global Production Market Share of Acne Drugs by Type in 2016 Figure Acne Drugs Product Picture and Specifications of Injection Figure Global market size and Growth rate of Injection in 2012-2017 Figure Acne Drugs Product Picture and Specifications of External Figure Global market size and Growth rate of External in 2012-2017 Figure Global Consumption Volume Market Share of Acne Drugs by Applications in 2016 Figure Teenagers Examples Figure Adult Examples Figure Global Production and Growth rate of Acne Drugs in 2012-2017 Figure Global Production of Acne Drugs by Region in 2012-2017 Figure Global Production Growth rate and demand Growth rate of Acne Drugs in 2012-2017 Figure Global Acne Drugs Industry gross Margin level 2012-2017 Figure Global Acne Drugs Major Manufacturers gross Margin in 2016 Figure Global Acne Drugs Industry Supply & Consumption comparative analysis 2012-2017 Figure Global Supply market share by Region in 2016 Figure Global ...
[154 Pages Report] Check for Discount on Global Prescription Dermatological Drug Industry 2016 Market Research Report report by QYResearch Group. The Global Prescription Dermatological Drug Industry 2016 Market Research Report...
[130 Pages Report] Check for Discount on United States Migraine Drugs Industry 2016 Market Research Report report by QYResearch Group. The United States Migraine Drugs Industry 2016 Market Research Report...
The relationship between physicians and the pharmaceutical industry has evoked heated debate for many decades.1 In 2012, the pharmaceutical industry spent $89.5 billion on physician-pharmaceutical sales representative (PSR) interactions that accounted for 60% of the global sales and marketing spending.2-8 Previous reports have demonstrated that PSRs may influence prescribing behaviour.9-16 However, the evidence determining whether pharmaceutical industry and PSRs interactions influence physicians is divided and contradictory. Studies have indicated that physicians may be unable to distinguish between promotional information and scientific evidence.17 18 Physicians, however, believe their colleagues are more susceptible to pharmaceutical industry marketing strategies than themselves.19-22 The majority of the physicians do not believe that they are affected by pharmaceutical industry and PSR interactions. Most medical and governmental institutions have installed guidelines and self-regulatory and ...
An article that emphasizes, what the typical work day of a pharmaceutical representative is like. From the beginning of the day,including pre-call to post call planning at the end. Other pertinent durites are also mentioned in the article,which is related to this often ludicrous career field.
This paper aims to analyse changes in the retail pharmaceutical market following policy changes in the Farmácia Popular Program (FP), a medicines subsidy program in Brazil. The retrospective longitudinal analyses focus on therapeutic class of agents acting on the renin-angiotensin system. Data obtained from QuintilesIMS (formerly IMS Health) included private retail pharmacy sales volume (pharmaceutical units) and sales values from 2002 to 2013. Analyses evaluated changes in market share following key FP policy changes. The therapeutic class was selected due to its relevance to hypertension treatment. Market share was analysed by therapeutic sub-classes and by individual company. Losartan as a single product accounted for the highest market share among angiotensin II antagonists. National companies had higher sales volume during the study period, while multinational companies had higher sales value. Changes in pharmaceutical market share coincided with the inclusion of specific products in the ...
drugs manufacturers & drugs suppliers directory. Browse china drugs products,Choose Quality drugs manufacturers, suppliers, factory at Tradett.com.
This handbook features contributions from a team of expert authors representing the many disciplines within science, engineering, and technology that are involved in pharmaceutical manufacturing. They provide the information and tools you need to design, implement, operate, and troubleshoot a pharmaceutical manufacturing system. The editor, with more than thirty years experience working with pharmaceutical and biotechnology companies, carefully reviewed all the chapters to ensure that each one is thorough, accurate, and clear ...
Impact of National and International Regulations on Indian Generic Drugs Industry: 10.4018/978-1-5225-2414-4.ch004: This article looks at evolution of the intellectual property right laws in India with regard to pharmaceutical drugs, and their impact on the pharmaceutical
Modern pharmaceutical manufacturing techniques frequently rely upon biotechnology. Amongst the earliest uses of biotechnology in pharmaceutical manufacturing is the use of recombinant DNA technology to modify Escherichia coli bacteria to produce human insulin, which was performed at Genentech in 1978. Prior to the development of this technique, insulin was extracted from the pancreas glands of cattle, pigs, and other farm animals. While generally efficacious in the treatment of diabetes, animal-derived insulin is not indistinguishable from human insulin, and may therefore produce allergic reactions. Genentech researchers produced artificial genes for each of the two protein chains that comprise the insulin molecule. The artificial genes were "then inserted... into plasmids... among a group of genes that" are activated by lactose. Thus, the insulin-producing genes were also activated by lactose. The recombinant plasmids were inserted into Escherichia coli bacteria, which were "induced to produce ...
This study focuses on Chinas Brain Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed Chinas society and economy. China is one of the worlds major producers for industrial and consumer products. Far outpacing other economies in the world, China is the worlds fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market ...
This study focuses on Chinas Lymphoma Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed Chinas society and economy. China is one of the worlds major producers for industrial and consumer products. Far outpacing other economies in the world, China is the worlds fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market ...
The Certified National Pharmaceutical Representative program will help you become an entry-level, certified pharmaceutical sales representative, even if you dont have pharmacology or medical education. 
The Certified National Pharmaceutical Representative program will help you become an entry-level, certified pharmaceutical sales representative, even if you dont have pharmacology or medical education. 
OrbisResearch.com has published new research report on "Global Peripheral Vascular Disease (PVD) Drug Industry 2012-2022 Market Research Report" to its database.. The Global Peripheral Vascular Disease (PVD) Drug Market report has key insights on the global Peripheral Vascular Disease (PVD) Drug Market for the clients who wish to broaden their spectrum in the market and expand their reach. Individuals interested in the report for purely academic purposes also have a substantial amount of data presented to suit their requirements.. The Global Peripheral Vascular Disease (PVD) Drug Market is being actively pursued by a substantial amount of key players across the globe. The market is caught major traction, especially in China which is the reason for the key insights presented in this report for China, along with the globe.. Major Global Markets Thrive with China Holding the Largest Piece of the Pie. The Chinese market for Peripheral Vascular Disease (PVD) Drug has picked up major pace owing to the ...
North Carolinas Senator of the moment, Richard Burr, spoke out strongly at a GlaxoSmithKline forum yesterday, stating that government involvement in health reform would adversely affect the drug industry. How? They might make fewer profits and have less incentive to bring all those desperately-needed (and heavily advertised) drugs to market.. Burrs other comment was just as illuminating. When asked to point to how government involvment in health care was detrimental to the system, he mentioned Medicare and Medicaid. Burr should know that right here in North Carolina we have a national model Medicaid primary care program - Community Care - that is providing first-class health care to children and parents and saving - thats right, saving - the state hundreds of millions of dollars every year. Look like private insurance could stand to learn a thing or two from North Carolinas Medicaid program. Thats good, because nobody will learn much of anything from Senator Burr.. ...
Global and Chinese Ischemia Reperfusion Injury Drug Industry, 2017 Market Research Report Size and Share Published in 2017-07-19 Available for US$ 3000 at Researchmoz.us
Global and Chinese Arteriovenous Fistula Drug Industry, 2017 Market Research Report Size and Share Published in 2017-07-19 Available for US$ 3000 at Researchmoz.us
Buy Panoxen Spray - packet of 30 gm Spray at online at 1mg.com. Know the uses, side effects, price, composition, substitutes, How it works, Precautions and Expert Advice for Panoxen Spray manufactured by Anglo-French Drugs & Industries Ltd
Terence Endorses Vanessas Law in the House of Commons On March 28, 2014 More about Terence Young, Member of the Canadian Parliament for Oakville, Ontario, Canada Excerpts from his speech: What They Never Talk About The drug industry representatives who infest parliament hill love to talk about when doctors make errors, or patients take the wrong…
Reportlinker.com announces that a new market research report is available in its catalogue: Global Anemia Drugs industry http://www.reportlinker.com/p0197179/Global-Anemia-Drugs-in
Drug Industry Payments Controversy. Late last year, we wrote about prominent Emory University professor Charles Nemeroff who lost his chairmanship.
Rapid Life Drugs & Healthcare | Pharmaceutical Drug - Manufacturer of Pharma Franchise Opportunity, PCD Pharma Franchise and Pharmaceutical Marketing Services from Panchkula
LONDON, UNITED KINGDOM--(Marketwire - July 16, 2008) - Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023http://www.reportlinker.com/p090927/The-Indian-Pharmaceutical-Market-Analysis-and-Forecasts-2008-2023.htmlThe pharmaceutical industry is one of the fastest growing sectors in Indian economy. Visiongain predicts that market...
Dendrite International, Inc., a leading provider of pharmaceutical industry solutions, today announced a comprehensive three-year agreement to provide SINE Pharmaceutical Company Co., Ltd, a subsidiary of Shanghai Pharmaceutical Group Co., Ltd (SPGC) and pioneer in Chinas growing pharmaceutical market, with components of Dendrites Sales Solutions.
The pharmaceutical market in Russia is one of the fastest growing globally and is set to rise from $20.91 billion in 2016 to $38.56 billion by 2021, representing a compound annual growth rate of 13%, according to GlobalData, a recognized leader in providing business information and analytics.. The companys latest report states that key drivers of the Russian healthcare market include improving regulatory guidelines and government initiatives to develop the domestic pharmaceutical industry. The Federal Drug Reimbursement Program, for example, provides uniform, free access to over 350 drugs for the most vulnerable social groups of the country.. The implementation of a state program to improve the healthcare industry by the Russian Ministry of Industry and Trade has also had a positive impact on domestic production. The programs main goals are developing domestic medicine production, developing the domestic production of medical devices, and improving state regulations for the circulation of ...
Get Information of Drugs Manufacturers, Suppliers, Dealers, Exporters, Traders, Producers, Wholesalers, Drugs Companies in Pune, India
Manufacturer of Pharmaceutical Manufacturing Services - Pharma Contract Manufacturer, Pharmaceutical Contract Manufacturing Services, Pharma Third Party Manufacturer offered by Deepar Pharmaceuticals Pvt Ltd, Jaipur, Rajasthan.
Research that assesses the implications of life-cycle management in the pharmaceutical market is rare, and the practice continues as health care costs continue to accelerate, which make the analysis by Nathalie Vernaz and colleagues particularly timely. Studying prescription rates in the Swiss canton of Geneva, the authors focused on eight drugs that demonstrate a wide array of evergreening strategies, including single-isomer versions marketed in place of enantiomeric drugs (e.g., levocetirizine and cetirizine), combination products marketed in place of unitary products (e.g., simvastatin/ezetimibe and simvastatin), and slow-release formulations (e.g., extended-release zolpidem and zolpidem). Among all of these examples, the follow-on product had no proven clinical advantage. Vernaz et al. found that the canton, which represents about 5% of Switzerlands total population, would have saved over 30 million Euros between 2001 and 2008 if physicians had avoided the high-cost follow-on products and ...
This research service presents the findings on the pharmaceutical market in Ethiopia. The research service presents an overview of the healthcare and pharmaceutical industry structure of the country. The market size and growth of the total Ethiopian pharmaceutical market, including six main therapeutic segments that characterize the prescription drug market are presented. A brief competitive overview is provided for the total market. Insight into the market dynamics, particularly the drivers and restraints as well as the opportunities of the pharmaceutical market, is provided in this research service.
LEXICARE PHARMA PVT. LTD. - Manufacturer,Exporter,Supplier of AntiUlcer Drug from Ankleshwar,Gujarat,India.Find more business detail of AntiUlcer Drug manufacturers, AntiUlcer Drug suppliers
LEXICARE PHARMA PVT. LTD. - Manufacturer,Exporter,Supplier of Antimalarial Drugs from Ankleshwar,Gujarat,India.Find more business detail of Antimalarial Drugs manufacturers, Antimalarial Drugs suppliers
Liquids Range in Chennai,Liquids Range in Chennai, Pharmaceutical Product Manufacturers in Chennai. pharma company in Himachal Pradesh, pharmaceutical company in Himachal Pradesh, pharma pcd company in Chennai, pharmaceutical company in Chennai, pharma franchise company in in Chennai, pharma franchise company, pharma franchisee company, pharma franchisee company in Chennai, pharma franchisee company in india, pharmaceuticals company, pharma pcd monopoly rights of pharmaceutical products, veterinary products, company, pharmaceutical drug manufacturer, pharma third party manufacturing, pcd franchise, PCD Franchise, monopoly rights, pharma monopoly rights in Chennai, pharmaceuticals distributorship in in Chennai
Search Indian Cancer Drugs Manufacturers and Suppliers Details - Contact to Cancer Drugs Exporters in India, Cancer Drugs Wholesalers, Cancer Drugs Distributors and Traders from India.
... , At least 43 drug factories supplying medication to thousands of U.S. consumers have received government warnings in recent months for failing to correct shoddy manufacturing practices that may have exposed patients to health risks, a USA Today review of records shows.
A generic drug manufacturer with operations in Miramar and Weston is considering a move to Coral Springs to expand, which would create more than 100 new jobs. The company plans an initial capital
Discount On Prescriptions To American Citizens. Compare Prescription Drug Prices. Cipro Drug Manufacturer. Online Seller Of Generic Drugs And Brand Name Medicine.
"Drug Industry Documents Archive. Retrieved 18 April 2013.. *^ Fugh-Berman, AJ (Sep 7, 2010). "The haunting of medical journals ... Godlee, F.; Groves, T. (2012). "The new BMJ policy on sharing data from drug and device trials". BMJ. 345: e7888. doi:10.1136/ ... were initially made publicly available on the PLOS Medicine website but they are now available as part of the Drug Industry ... from the drug's manufacturer Roche.[24] The article outlined the need for access to all clinical trial data held by ...
Guidance for Industry and Food and Drug Administration Staff.[11]. *ICH E5 (R1): Ethnic factors in the acceptability of foreign ... Rare diseases: Common issues in drug development. Guidance for industry. (PDF), U.S. Department of Health and Human Services; ... It also covers drug drug interaction studies.. References classified by therapeutic area[edit]. Chronic obstructive pulmonary ... FDA Rare diseases: Common issues in drug development.[7] Guidance for industry. ...
UN Report: Afghanistan's Drug Industry (PDF, 223 pages). *Afghanistan: Drug Industry and Counter-Narcotics Policy, World Bank ... Drug cartel. References[edit]. *^ a b c d "Interpol: Drugs Sub-Directorate: Heroin". Interpol. 2007. Retrieved 2007-07-05.. .mw ... "Drug Trafficking". United Nations Office on Drugs and Crime. Retrieved 20 May 2012.. ... The United Nations Office on Drugs and Crime (UNODC) heroin production estimates for the past 10 years show significant changes ...
"Youth Violence, Guns, and the Illicit-Drug Industry". 86 J. Crim. L. & Criminology 10 (1995-1996). JSTOR 1143998.. ... Some groups, such as the Fang of Gabon consume eboga (Tabernanthe iboga), a mind-altering drug in religious rituals. In modern ... "Where there's smoke, there's Kretek: the cigarette industry in Indonesia". Website of US Embassy in Jakarta. June 3, 1999. ... The main threat to the tobacco industry is the rise in popularity of e-cigarettes. Some people praise them for helping people ...
Main articles: Drug discovery and Drug development. Drug discovery is the process by which potential drugs are discovered or ... "U.S. Food and Drug Administration. Retrieved 31 May 2007.. *^ "The Orphan Drug Act (as amended)". U.S. Food and Drug ... The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to ... Unsafe drugs and early industry regulationEdit. In 1937 over 100 people died after ingesting a solution of the antibacterial ...
Drug & Cosmetic Industry. February 1889: 34 Official website. ...
"The Horseracing Industry: Drugs, Deception and Death". PETA Media Center. People for the Ethical Treatment of Animals. Archived ... "Barbaro's Tragic Injury: A Symptom of a Cruel Industry". PETA.org Campaigns. People for the Ethical Treatment of Animals. ... The Thoroughbred industry is a large agribusiness, generating around $34 billion in revenue annually in the United States and ... animal rights groups have denounced the Thoroughbred racing industry.[135] On the other hand, advocates of racing argue that ...
Hemp Industries Ass'n v. Drug Enforcement Admin., 333 F.3d 1082 (9th Cir. 2003) ... individual industries, Federal, State, or local government agencies, or geographic regions," or (3) "significant adverse ...
"About the Project". Drug Industry Documents Archive. Retrieved 18 April 2013. Fugh-Berman, AJ (Sep 7, 2010). "The haunting of ... were initially made publicly available on the PLOS Medicine website but they are now available as part of the Drug Industry ... Godlee, F.; Groves, T. (2012). "The new BMJ policy on sharing data from drug and device trials". BMJ. 345: e7888. doi:10.1136/ ... 20 Dec 2012 (2012-12-20). "EMA workshop reveals divisions with industry . ecancer - News". Ecancer.org. Retrieved 2013-04-26. " ...
He was a grandson of William Davis Ticknor, founder of the publishing ... "William D. Ticknor". Drug and Cosmetic Industry. ...
"Drug Industry Document Archive". http://dida.library.ucsf.edu/. University of California, San Francisco. March 12, 2012. ... It was later found that the article had been ghostwritten by Scientific Therapeutics Information on behalf of the drug company ...
Statisticians in the Pharmaceutical Industry; the Drug Information Association; the Royal Statistical Society; and the ...
Matthew Herper, Can Bush's NIH Chief Fix the Drug Industry, Forbes *^ a b c Luke Timmerman, Harvard's Verdine Seeks Blaze Trail ... A close analog of a stapled peptide drug invented in the Verdine Lab at Harvard is currently in Phase II clinical development ... He has co-founded ten drug discovery companies, including six that have been listed publicly listed on the NASDAQ and one ... His companies have succeeded in developing two FDA-approved drugs, Romidepsin and Paritaprevir. Verdine is the co-inventor with ...
"FDA approves Striverdi Respimat to treat chronic obstructive pulmonary disease". FDA News/Drug Industry Daily. 31 July 2014. ... To judge from the drug's mechanism of action and from experiences with related drugs, hypertension (high blood pressure), ... On 29 January 2013 the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) recommended ... ISBN 3-85200-196-X. Hollis A (31 January 2013). "Panel Overwhelmingly Supports Boehringer COPD Drug Striverdi". FDA News/Drug ...
Reporter for the Chain Drug Store Industry". Chain Drug Review. 2013-05-15. Archived from the original on 26 August 2014. ... Almus is a brand of generic prescription drugs sold in five countries. Almus is an umbrella brand for the wide range of lower ... "Chain to review drug charges as huge price gaps uncovered". Irish Independent. 9 July 2011. "Retail Week". October 2013. " ... List of pharmaceutical companies Pharmaceutical industry in Switzerland "Archived copy". Archived from the original on 20 May ...
Guidance for Industry: Frequently Asked Questions About Medical Foods; Second Edition U.S. Food and Drug Administration (May ... Medical Foods - Guidance for Industry: Frequently Asked Questions About Medical Foods; Second Edition U.s. Food and Drug ... "New Dietary Ingredients in Dietary Supplements - Background for Industry". US Food and Drug Administration. August 2016. ... Food and Drug Administration ("FDA"). Pursuant to the Federal Food, Drug, and Cosmetic Act ("the Act") and accompanying ...
Hall, M. Floyd (May 7, 1995). "Caregiver Drug Buy Raises Industry Issues". The Morning Call. Retrieved May 28, 2015. Graham, ... In 1995 the company attracted media attention when one of its home care employees was arrested while buying illegal drugs, and ...
Hall, M. Floyd (7 May 1995). "Caregiver Drug Buy Raises Industry Issues". The Morning Call. Retrieved 28 May 2015. George, John ... In 1995 the company drew negative attention when one of its home care employees was arrested while buying illegal drugs, and ... Griswold was among the corporations that pushed for better government oversight of the home care industry. Griswold hired Ray ...
"China Orders Investigation into Drug Industry." BBC News. February 9, 2007. BBC News "200 remain hospitalized for food ... The drug quality inspectors at the factory that produced the Armillarisni A drugs failed to notice that the chemical diglycol ... The State Food and Drug Administration reported that their officials had resolved 14 cases involving fake drugs and 17 cases ... People's Daily News "China to Tighten Drug Safety Checks." China Daily. February 27, 2007. Xinhua "Death Toll Over Fake Drug ...
The drug industry spent at least $106 million lobbying Congress on the legislation between 2014 and 2016. McKesson Corporation ... Higham, Scott (October 15, 2017). "The drug industry's triumph over the DEA". Chicago Tribune. Retrieved 18 October 2017. Lenny ... Bill H.R.3261 "How Congress allied with drug company lobbyists to derail the DEA's war on opioids". Washington Post. Retrieved ... O'Keefe, Ed (October 16, 2017). "Trump promises to 'look into' report on drug czar nominee Marino in wake of Post/'60 Minutes' ...
"Drug Industry Helping Obama Overhaul Health Care". FoxNews.com. 8 August 2009. Retrieved 30 May 2013. "In Negotiations, ...
Pollack, Andrew (20 April 2001). "Defensive Drug Industry: Fueling Clash Over Patents". New York Times. Retrieved 27 February ... She won several awards for her work on the effects of exposure to the drug diethylstilbestrol (DES) in the 1980s and 1990s, ... of the independent medicines journal La Revue Prescrire/Prescrire International and the International Society of Drug Bulletins ...
"Teva Bolsters Position With Acquisitions.(Teva Pharmaceutical Industries Ltd.)". Chain Drug Review. September 25, 2000. ... At the time, Novopharm was Canada's second largest drug manufacturer. Teva, a generic drug manufacturer based in Jerusalem, ... The company expanded to become Canada's second largest generic drug manufacturer and it also owned sites in the US and Hungary ... The acquisition made Teva the largest generic drug company in North America. Teva Canada maintains several facilities in the ...
He has studied the generic drug industry. His work appears in Slate. Prescribing by Numbers: Drugs and the Definition of ... ISBN 978-1-4214-1493-5. Golden, Janet (October 7, 2014). "Generic drugs: An interview with Jeremy Greene". The Philadelphia ...
The technique is commonly used in the pharmaceutical industry to characterize potential drug candidates. ... This is the standard used in industry to measure heats since industrial processes are engineered to run at constant ...
Houston Raceway is a motorsports complex featuring National Hot Rod Association (NHRA) races and a weekly drag racing program. ... In addition to the heavy industry in the business community, Baytown is home to the Cedar Crossing Industrial Park. With a ... The industries located along the ship channel and the bay are a major cause of the pollution.[25] ...
... she shouldnt have to worry that the drug was selected because of a pharmaceutical companys marketing skills. Thats why ... The drug industry says such bans, which also have been enacted in the last two years by Yale University and the University of ... The drug industry doles out $21 billion a year in marketing (90% directed at physicians), far more than it spends on consumer ... Stanfords decision also is further proof that voluntary drug industry guidelines arent working, as if that is a surprise. ...
The real problem is that we in the drug industry havent been discovering enough useful new drugs. As someone who works in the ... Those of us in the drug industry dont really know what to expect from the Obama administration (although were pretty sure ... All of those issues affect drug prices, but you have to have something to sell before you can talk about its price. ... For another thing, weve learned a lot more about potential problems with drug candidates, but not so much about how to fix ...
PHARMACEUTICAL company executives are watching nervously as drug prices come under growing criticism in Congress and states ... Business and Health; Drug Industry Nervous on Prices. By Milt Freudenheim Published: May 22, 1990. ... Most big drug companies oppose giving Medicaid discounts to the states, which spend $3.5 billion on drugs in Medicaid programs ... Makers of such drugs would have to bid against each other. Different drugs have different properties and different side ...
200-billion-a-year industry and the 176-nation World Customs Organization (WCO) will sign a declaration later this month to ... PARIS (Reuters) - Counterfeit drugs have become a $200-billion-a-year industry and the 176-nation World Customs Organization ( ... "We have more fakes than real drugs in the market," said Christophe Zimmermann, the WCOs anti-counterfeiting and piracy ... The World Trade Organization says fake anti-malaria drugs kill 100,000 Africans a year and the black market deprives ...
Why The Drug Industry Isnt Focusing On Americas Biggest Killer. There are more medicines in late-stage development for cancer ...
I simply would like a list of the drugs which have ,been researched, developed and marketed by a non-industry system. Well, ... Unethical practices - drug industry. Bret Jwood Jill Wood jwood at teleport.com Fri Sep 1 10:05:03 EST 1995 *Previous message: ... most ethical industries list. When the profit is high enough, I imagine the drug companies would do just about anything they ... Also, how about considering the medication Procardia..... It was on the list of the top 10 drugs in the US on sci.med, and it ...
The Wall Street Journal recently reported a story about Xigris, Eli Lillys new antisepsis drug. Sepsis, an infection of the ... How the drug industry is branding itself with bioethics.. By Carl Elliott ... The drug industry has even managed to turn peer-reviewed scientific literature into a sophisticated marketing device. It has ... Often, when a drug company is launching a new drug, it recruits a third party known as a Key Opinion Leader: an influential ...
Food and Drug Industry The Economy, Industry and Development Issues ... The Economy, Industry and Development Issues Current news and events with regards to the economy, industry and urban ... SkyscraperCity , Asian Forums , Philippine Forums , Around the Philippines , The Economy, Industry and Development Issues ...
... consumer outrage grows over prescription drug prices, state authorities and patient advocates in Maryland are preparing to ... but the Maryland law is one of a few drawing the most attention from the drug industry. ... "The issue of drug pricing is a national issue ... not something that should be handled piecemeal in 50 different ways," said ... Nevada has been sued by two industry trade groups after passing in June a law requiring diabetes drugmakers to justify price ...
Wuergler says generic drug manufacturers do not operate at the same profit margins as well-known brands. "They tell me that the ... James says the nature of the industry means that a risk-based approach has to be taken. Sometimes a new partnership link is ... "I think regulation is an issue, but, unlike the retail sector, where the Payment Card Industry Data Security Standard has given ... And in the manufacturing area they are clearly aware that a malicious attack that produces bad drugs would be disastrous for ...
... Share this:. *Click to share on Facebook (Opens in new window) ... after his company raised the price of the anti-infection drug Daraprim by more than 5,000 percent. The drug, which Turing ... "We need to get to the bottom of why were seeing huge spikes in drug prices that seemingly have no relationship to research and ... The lawmakers question Retrophin about its decision to raise the price of a kidney drug, Thiola, from $1.50 per tablet to $30 ...
It is a high molecular weight heparin drug ranging from 3,000 Da to 30,000 Da. The unfractionated... ... Unfractionated heparin drug is an anticoagulant drug. It is a high molecular weight heparin drug ranging from 3,000 Da to ... Unfractionated Heparin Drug Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025. Press ... The unfractionated heparin drug is a heterogeneous mixture of linear polysaccharide chains with variable biological activity ...
Kennedy: Medicinal marijuana is a Trojan horse for the recreational drug industry. ... In Rhode Island, where the district he represented in Congress is located, drug overdoses are a public health crisis. The ... Kennedy argues that lack of regulation in the pharmaceutical and alcohol industries is a prime example of why marijuana could ... making the drug seem more normalized and acceptable in society, though it still has dangerous impacts on minors. "The public ...
... ... PBMs are middlemen between drug makers and consumers when it comes to purchasing drugs and providing prescription coverage. The ... PBMs are middlemen between drug makers and consumers when it comes to purchasing drugs and providing prescription coverage. The ... Avista healthcare industry executive Charles Harwood said United BioSource has contributed unique capabilities and insights to ...
Study finds tobacco companies in 1980s and 1990s put pressure on drug companies to limit their marketing of nicotine gum and ... The drug companies then toned down their marketing strategies, the study says, focusing on smokers who had already decided to ... Tobacco companies in the 1980s and 1990s put pressure on drug companies to limit their marketing of nicotine gum and skin ... While the study focused on Philip Morris, other tobacco companies were also involved in pressuring the drug companies, Dr. Bero ...
Nasal Drug Delivery Technology market worldwide is projected to grow by US$25.4 Billion , driven by a compounded growth of 6.2 ... Global Nasal Drug Delivery Technology Industry. Tuesday, December 10, 2019 Drug News ... Nasal Drug Delivery Technology Market Review in China in US$ Million by End-Use: 2009-2017 Table 78: Chinese Nasal Drug ... Nasal Drug Delivery Technology Market Review in Italy in US$ Million by End-Use: 2009-2017 Table 129: Italian Nasal Drug ...
The Latest Reports with Statistics & Trends from Top Industry Sources. ... Understand the Allergy Drug Industry Quickly & Get Actionable Data Easily. ... Allergy Drugs Industry Forecasts - China Focus March 2018 $ 1800 The 2019-2024 World Outlook for Allergy Drugs January 2018 $ ... Allergy Rhinitis Drugs Sector: Worldwide Forecast until 2021 May 2017 $ 2500 Allergy Drugs Companies in China March 2018 $ 1800 ...
Report: Drug stocks prey for insiders as industry resists change Updated: December 21, 2012 - 9:18 AM EST * ... "The industry isnt capable or willing to regulate itself," Singer was quoted as saying. ... regulators for insider trading gained their edge as a result of secret information about drugs, devices and the companies that ...
Pharmaceutical Industry, Drug Quality and Regulation: Evidence from US and Italy. Vincenzo Atella, Jay Bhattacharya, Lorenzo ... Published: Pharmaceutical industry, drug quality and regulation.Evidence from US and Italy Journal Article Authors Vincenzo ... This paper examines the relationship between drug price and drug quality and how it varies across two of the most common ... Second, an MES+PC mix reduces the difference in price between the highest and lowest quality drugs on the market. The empirical ...
Drug Industry, Nonprofits Join Forces To Fight Worlds Neglected Diseases. by Sam Savage ... Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected ... particularly the wide gap between drug need and availability. But challenges remain, including who will pay for the drugs and ... Even though drug companies can expect to profit little from these ventures, a growing number see it as good business and are ...
... of people in the developing world are hanging in the balance ahead of a ruling that will determine whether Indias drug ... Indias Supreme Court to Rule on Generic Drug Industry. The lives of millions of people in the developing world are hanging in ... With no costs for developing new drugs or conducting expensive trials, Indias $26 billion generics industry is able to sell ... The case - involving Swiss drug maker Novartis AGs cancer drug Glivec - pits aid groups that argue India plays a vital role as ...
The drug industry goes beyond crony capitalism when it then charges Americans the highest drug prices in the world. ... The financial rip-offs arent the only problems with the out-of-control drug industry. Federal law requires all approved drugs ... the drug industry is required by law to fund a large portion of the FDAs drug review budget, which contributes to this weak ... variations on older drugs." Dr. Angell charges that the industry is "primarily a marketing machine to sell drugs of dubious ...
... By Karen Blum ... Partnering with Industry for Better Education in Drug Discovery. .related-content { clear:both; } p.related-pubs-title { text- ... "My goal is to build a model and introduce different drugs or therapies into it to better understand the mechanisms of how drugs ... For a drug to stay in the body and not be seen as foreign by the immune system, Majewska says, it needs to possess a specific ...
"Pharmaceutical industry regulation undermines NICE drugs appraisal work ." Medical News Today. MediLexicon, Intl., 4 May. 2015 ... Publications, S. (2015, May 4). "Pharmaceutical industry regulation undermines NICE drugs appraisal work ." Medical News Today ... Visit our Pharma Industry / Biotech Industry category page for the latest news on this subject, or sign up to our newsletter to ... To illustrate how policy may support the pharmaceutical industry at the expense of the NHS, the authors give an example of how ...
Posts tagged with "Drug Industry History". * Academia (vs. Industry) What Happens to University-Based Biotech Startups - And ... Drug Industry History 1989. 1 November, 2019. I have an anniversary to celebrate this time of year: its now been thirty years ... Revenues From New Drugs - And Thoughts on Chance. 12 July, 2019. Heres an interesting analysis of the industry from IDEA ... Derek Lowes commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of ...
  • After threats from Congress to crack down on industry swag, manufacturers agreed in 2002 to limit gifts to those of "modest value. (latimes.com)
  • Only 15 new drugs were approved by America's drugs agency, the Food and Drug Administration, during 2002 compared with an average during the previous five years of 31. (healthy.net)
  • Three of the largest pharmaceutical companies - Merck, Bristol-Myers Squibb, and Burroughs-Wellcome - have broken with the industry's longstanding policy of refusing to offer discounts on Medicaid drugs. (nytimes.com)
  • Most big drug companies oppose giving Medicaid discounts to the states, which spend $3.5 billion on drugs in Medicaid programs. (nytimes.com)
  • The executive committee of the board of the Pharmaceutical Manufacturers Association, a trade group, met on May 3 and formally rejected ''proposals to tie the availability of prescription drugs to the willingness or ability of companies to grant discounts or rebates. (nytimes.com)
  • The whole issue of pricing is a very serious one for the companies and their stock price-earnings ratios,'' said Hemant K. Shah, an independent pharmaceutical analyst in Warren, N.J. ''Drug unit sales are declining and about 70 percent of sales growth is coming from price increases. (nytimes.com)
  • Indeed, he added, one advantage for investors of having drug stocks had been that the companies could always raise the prices of their products, even in a recession. (nytimes.com)
  • Jim Parks, who heads the $570 million Medi-Cal Drug Discount Program in California, said that ''a couple of companies are showing interest'' in discussing discounts. (nytimes.com)
  • When the profit is high enough, I imagine the drug companies would do just about anything they felt they could get away with in order to maintain their cash-flow. (bio.net)
  • To answer that question, we need to ask another one: Why do drug companies want to give money to bioethicists in the first place? (slate.com)
  • While KOLs are frequently offered positions as consultants or advisers, the drug companies do not expect them to push their products directly. (slate.com)
  • Some public relations agencies advise drug companies to encourage their KOLs to work for many different companies in order to maintain a posture of objectivity. (slate.com)
  • not something that should be handled piecemeal in 50 different ways," said Jeff Francer, general counsel for the trade group which represents companies like Teva Pharmaceutical Industries Ltd and Novartis AG's Sandoz unit. (reuters.com)
  • WASHINGTON - A Senate committee has launched an investigation into exorbitant drug price hikes by Turing Pharmaceuticals and three other companies, responding to public anxiety over rising prices for critical medicines. (denverpost.com)
  • Avista healthcare industry executive Charles Harwood said United BioSource 'has contributed unique capabilities and insights to the biopharmaceuticals industry, which have enabled countless pharmaceutical companies to accelerate approvals of their therapies, expand access to patients in need, and help ensure medications are safe to use. (forbes.com)
  • Tobacco companies in the 1980's and 1990's put pressure on drug companies to limit their marketing of nicotine gum and skin patches that help people quit smoking, according to a new study of tobacco industry documents. (nytimes.com)
  • The drug companies then toned down their marketing strategies, the study says, focusing on smokers who had already decided to quit rather than making broader appeals based on the health benefits of quitting. (nytimes.com)
  • While the study focused on Philip Morris, other tobacco companies were also involved in pressuring the drug companies, Dr. Bero said. (nytimes.com)
  • The story said that since 2007, 97 people charged or sued by U.S. regulators for insider trading gained their edge as a result of secret information about drugs, devices and the companies that make them, according to data compiled by Bloomberg. (philly.com)
  • Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. (redorbit.com)
  • C&EN Senior Editor Lisa Jarvis explains that just a decade ago major pharmaceutical companies had largely abandoned developing treatments for these neglected diseases. (redorbit.com)
  • The article describes how public-private partnerships between drug companies, nonprofits, and philanthropists are springing up to address this problem, particularly the wide gap between drug need and availability. (redorbit.com)
  • Even though drug companies can expect to profit little from these ventures, a growing number see it as good business and are excited about a steady stream of new drug candidates, the article notes. (redorbit.com)
  • The lives of millions of people in the developing world are hanging in the balance ahead of a ruling that will determine whether India's drug companies can continue to provide cheap versions of many life-saving medicines. (law.com)
  • From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will determine whether India's drug companies can continue to provide cheap versions of many life-saving medicines. (law.com)
  • The case - involving Swiss drug maker Novartis AG's cancer drug Glivec - pits aid groups that argue India plays a vital role as the pharmacy to the poor against drug companies that insist they need strong patents to make drug development profitable. (law.com)
  • With no costs for developing new drugs or conducting expensive trials, India's $26 billion generics industry is able to sell medicine for as little as one-tenth the price of the companies that developed them, making India the second-largest source of medicines distributed by UNICEF in its global programs. (law.com)
  • Indian pharmaceutical companies such as Cipla, Cadila Laboratories and Lupin have emerged over the past decade as major sources of generic cancer, malaria, tuberculosis and AIDS drugs for poor countries that can't afford to pay Western prices. (law.com)
  • But Western companies argued that India's generic manufacturers were cutting the incentive for major drug makers to invest in research and innovation if they were not going to be able to reap the exclusive profits that patents bring. (law.com)
  • International drug companies have accused India of disregarding intellectual property rights, and have pushed for stronger patent protection that would weaken India's generics industry. (law.com)
  • Public health activists say the question goes beyond Glivec to whether drug companies should get special protection for minor tweaks to medicines that others could easily have uncovered. (law.com)
  • t is remarkable what very profitable drug companies-as they merge into fewer giant multinationals-continue to get away with by way of crony capitalism. (counterpunch.org)
  • Some companies reaped billions of dollars in revenues when they were granted exclusive rights to market a drug, such as Taxol, developed by the government's National Institutes of Health (NIH). (counterpunch.org)
  • He said that drug companies, while not colluding, 'have all looked at each other and said, 'None of us needs to compete on price if we just hold the line. (counterpunch.org)
  • Over the years, the government has fined drug companies billions of dollars for pushing unapproved uses of drugs. (counterpunch.org)
  • In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. (mynewsdesk.com)
  • Hours after he insisted on national television that the $750-a-pill price on the formerly $18-a-pill drug was the right one for business reasons, he announced that he would lower the price - a move that galvanized critics and set a precedent for other companies to do the same. (washingtonpost.com)
  • At the time, PhRMA President John Castellani argued that the debate over drug pricing has gone "askew" and that research at development for such drugs comes at a high cost to companies. (washingtonpost.com)
  • We serve all sizes and types of companies spanning across various industries. (pitchengine.com)
  • And they will be there to see and learn firsthand about product and service offerings showcased by companies like yours that can enhance and increase the success of their drug free workplace programs. (datia.org)
  • Oxfam estimates the four drug companies avoided paying an estimated €3.16 billion in taxes in nine advanced economies and €95 million in six developing countries. (euractiv.com)
  • According to the report " Prescription for Poverty ", the drug companies appear to underpay an estimated €1.2 billion in taxes in six European countries (Denmark, France, Germany, Italy, Spain and the UK) over a three year period. (euractiv.com)
  • Drug companies appear to be cheating governments out of tax revenues that could be invested in healthcare. (euractiv.com)
  • Companies like those mentioned in the report follow accounting procedures and tax laws in the countries they operate in, paying taxes accordingly," a source from the European Federation of Pharmaceutical Industries and Associations (EFPIA) told EURACTIV. (euractiv.com)
  • There have been plenty of short-term studies funded by drug companies, but they are on the order of four to 12 weeks. (smokymountainnews.com)
  • Because of drug company funding of talks, lectures, symposia, medical school grants and generous funds from pharmaceutical companies, Dr. Portenoy and his like-minded colleagues have had lucrative and illustrious careers. (smokymountainnews.com)
  • How have the drug companies fared with this investment? (smokymountainnews.com)
  • Additionally, 67% of drug companies increased their annual profit margins during the same period-with margins up to 20 percent for some companies in certain years. (gao.gov)
  • About 67 percent of all drug companies saw an increase in their annual average profit margins from 2006 to 2015. (gao.gov)
  • For comparison, the annual average profit margin across non-drug companies among the largest 500 globally fluctuated between 4 and 9 percent. (gao.gov)
  • The largest 10 companies had about 38 percent of the drug industry's sales revenue in 2014. (gao.gov)
  • In addition, experts noted that market pressures such as rising research and development (R&D) costs, fewer drugs in development, and competition from generic drugs, have driven structural changes in the industry such as increased use of acquisition by large drug companies to obtain access to new research. (gao.gov)
  • In addition to grants, several federal tax provisions provided incentives for industry R&D spending, including the orphan drug credit, available for companies developing drugs intended to treat rare diseases, which increased more than five-fold from 2005 through 2014. (gao.gov)
  • As pharma companies underwrite three-fourths of the FDA's budget for scientific reviews, the agency is increasingly fast-tracking expensive drugs with significant side effects and unproven health benefits. (propublica.org)
  • In return for accelerated approval, drug companies commit to researching how well their drugs work after going on the market. (propublica.org)
  • The share of total clinical (industry-sponsored) clinical trials and the share of total clinical trial enrollment held by the top 10 companies has been declining pretty steadily over that time as well. (sciencemag.org)
  • The authors of this new paper identify several trends that have delayed the expected mega-consolidation of the industry - the move to rare diseases, the rise of monoclonal antibody therapies (done at first by a number of players outside the big 10 companies at the time), the greater availability of outsourced services, and - in recent years - the relatively easy access to capital. (sciencemag.org)
  • On average, each of these authors had dealings with 10.5 different drug companies. (ashp.org)
  • Six percent owned an equity stake in one or more drug companies. (ashp.org)
  • Although the survey s questions dealt with authors relationships with drug companies, the guideline topics were not restricted to drug therapy but also described diagnosis and other aspects of disease management. (ashp.org)
  • Fifty-nine percent of the 80 respondents who returned a follow-up survey acknowledged having a relationship with one or more companies whose drugs were considered in the guideline. (ashp.org)
  • Major drug manufacturers have looked to biotech companies to help offset major revenue losses from expiring patents as it is less time consuming than developing new drugs through R&D. (yahoo.com)
  • The report identifies the leading companies in the industry, and offers strategic analysis of the key factors influencing the market. (ibisworld.com)
  • HAWTHORNE , N.Y. An Israeli generic drug maker has sued three other companies, alleging patent infringement. (drugstorenews.com)
  • Major companies profiled in the drug delivery systems market include AstraZeneca plc. (bccresearch.com)
  • DIDA contains: internal pharmaceutical company documents correspondence between drug companies and physicians, researchers and educational institutions regulatory and legal documents court filings depositions expert reports internal University documents Documents come from a variety of sources including: Lawsuits against Merck & Co. regarding the marketing and use of Vioxx The landmark whistleblower case involving Neurontin (gabapentin) and off-label marketing: United States of America ex rel. (wikipedia.org)
  • Check out the Fool's new free report " Secure Your Future With 9 Rock-Solid Dividend Stocks ," where you'll find one drug developer and eight other promising companies. (fool.com)
  • Major ophthalmic companies from around the world are widening their focus on combination drugs - medications that involve the use of two or more medicines for retinal disorders. (sbwire.com)
  • THURSDAY, Sept. 27 (HealthDay News) -- Seven major pharmaceutical companies are banding together to develop genetic tests that predict which patients will have adverse side effects from drugs. (bio-medicine.org)
  • Whereas, on the basis of sales, data related to sales volume, sales price, cost, sales income, and profit margin etc. of Drug Injection Device Sales Industry used in different fields, sold in different regions and by different companies is provided in this report. (beforeitsnews.com)
  • Some economists and scientists suggest that companies have abused the financial incentives for rare-disease drug development, and they predict a coming backlash to the hefty price tags of these medications. (the-scientist.com)
  • And before the mid-1980s, when governments began passing legislation that encouraged companies to invest in these uncommon conditions, industry was reluctant to pour its money into products with such minuscule markets. (the-scientist.com)
  • If you look at it from an economic perspective, at the time there was a clear market failure-there was no incentive for companies to develop [an orphan] drug, it just didn't make sense," says Dyfrig Hughes, a health economist at Bangor University in the U.K. who is involved in clinical trials for rare conditions. (the-scientist.com)
  • Post-marketing studies are a major activity in the life cycle of a licensed drug/medicinal product and are regularly conducted by pharmaceutical companies and contract research organisations. (bmj.com)
  • According to the German Medicinal Products Act (Arzneimittelgesetz, AMG) all companies initiating a post-marketing study in the German drug market are required by law to register their study. (bmj.com)
  • Drugs) companies are beginning to shift research budgets towards more aggressive marketing of existing products. (healthy.net)
  • To encourage pharmaceutical companies to make more money (as if they've ever needed encouragement), the editors surmise that drug companies may be looking for the next blockbuster rather than developing a 'niche' drug. (healthy.net)
  • The FDA is expected to publish a series of notices in December formally approving the last of the drug companies' labeling changes, which are expected to be effective Jan. 1. (agri-pulse.com)
  • All companies agreed to end the sale of the drugs for growth promotion, and that effectively ends such usage, according to Michael Taylor, who stepped down earlier this year as FDA's deputy commissioner for foods. (agri-pulse.com)
  • More than 70 other drug companies have yet to disclose similar payments. (psychrights.org)
  • In addition, unprecedented growth in the development of clinical drugs and devices achieved by the large pharmaceutical companies are believed to meet the demand for advanced medication delivery technologies. (grandviewresearch.com)
  • Brook said: "It is worth asking whether any of this would have come about without the huge amount of public pressure and negative publicity around drugs companies' inappropriate behaviour with regards the aggressive promotion of certain antidepressants. (communitycare.co.uk)
  • Drug companies are under attack for what is seen as exorbitant pricing on new drugs, or for raising prices dramatically on drugs that have been in the market a while. (bdo.com)
  • The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry's value chain. (openpr.com)
  • The University of California, San Francisco Library created this digital archive in an attempt to facilitate further research into the drug industry's practice of establishing close links with the medical community which has been shown to influence scientific research, drug approval, prescription practices, and ultimately, consumer health. (wikipedia.org)
  • Join your colleagues and industry experts for the industry's premier educational event.With Over 600 attendees, 65 exhibitors, 25 educational sessions, and pre- and post-conference trainings this is your one-stop shop for staying current on what's happening in the drug and alcohol testing industry. (tsnn.com)
  • The "unusually large-scale" campaign "helps explain some of a contentious back-and-forth playing out in recent days" over the drug industry's pledge to contribute $80 billion over 10 years to health reform costs, the Times reports. (californiahealthline.org)
  • The industry's low esteem among the general public is a direct result of this bad behavior and not, as some industry defenders claim, due to skewed media reports and anti-industry books like "Bad Pharma" (see here ). (blogspot.com)
  • This is a driving factor for the growth of the global unfractionated heparin drug market. (mynewsdesk.com)
  • Much of this growth was driven by use of expensive brand-name drugs, but price increases have been reported for some generic drugs as well. (gao.gov)
  • IBISWorld's industry research report on Antiviral Drug Manufacturing provides up-to-date sales and market data, allowing you to identify the product and customer segments driving revenue growth. (ibisworld.com)
  • The primary reason for the growth of the global alcohol breathalyzer and drug testing equipment market is the growing consumption of alcohol and other intoxicating substances across the world. (sbwire.com)
  • Another factor promoting the growth of the global alcohol breathalyzer and drug testing equipment market is the growing demand for portable breathalyzers. (sbwire.com)
  • According to market analysts, the global ophthalmic drugs market will grow from USD 16 billion in 2012 to USD 21.6 billion in 2018, observing growth at an average CAGR of 5.2% during the next 4-5 years. (sbwire.com)
  • However, the market also has its own set of problems that may have a negative impact on its growth, namely the lack of awareness amongst the population about the benefits of early diagnosis, the lack of new formulations in the market, and patent expiry of some major drugs in the market. (sbwire.com)
  • Amongst these, the segment of anti-glaucoma drugs currently has the major shares of demand and is also expected to observe market growth at the fastest pace in the coming years. (sbwire.com)
  • The huge base of population in Asian countries such as China and India, a large share of which is getting old, is the major reason behind the enormous growth potential provided by this region for the ophthalmic drugs industry. (sbwire.com)
  • Presently, the global ophthalmic drugs market is experiencing good growth, albeit it remains constrained due to the lack of new formulas in the market. (sbwire.com)
  • They also have a role in viral entry, tumour growth, and metastasis, and as such, have received significant attention from the pharmaceutical industry. (diamond.ac.uk)
  • This repeated usage of injections to deliver insulin causes pain and increase the risk of infection transmission, thus leading to heightened growth prospects for alternative drug delivery modes. (grandviewresearch.com)
  • Or why the University of Chicago's MacLean Center for Clinical Medical Ethics cosponsored a recent conference with Pfizer, Merck, and PhRMA, the pharmaceutical industry trade organization, on inequities in American health care. (slate.com)
  • Key players operating in the global unfractionated heparin drug market include Dr. Reddy's Laboratories Ltd., Fresenius Kabi AG, LEO Pharma A/S, Pfizer, Inc., and Sanofi S.A. (mynewsdesk.com)
  • Bextra, sold by Pfizer, Inc., another anti-inflammatory analgesic drug was approved by the FDA in 2001, and was then removed in 2005 because of concerns about increased risk of heart attacks and strokes, as well as serious, sometimes fatal skin reactions. (counterpunch.org)
  • However, Pfizer has obtained market exclusivity for the drug and its use in pain management through to 2018, and is therefore expected to maintain its leadership position. (openpr.com)
  • Bruce Littman, president of Translational Medicine Associates, LLC, in Stonington, Connecticut, moved to an industry position at Pfizer after studying the pathogenesis of rheumatoid arthritis as a professor at Virginia Commonwealth University in Richmond. (sciencemag.org)
  • After a split vote by a Food and Drug Administration advisory panel, the agency will have the final say on whether Pfizer 's (NYSE: PFE) tafamidis meglumine is approved in the U.S. (fool.com)
  • The decision won't affect Pfizer all that much, but it could signal a major issue for the drug development industry in general. (fool.com)
  • This paper examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: minimum efficacy standards (MES) and a mix of minimum efficacy standards and price control mechanisms (MES+PC). (nber.org)
  • Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals and as a result it improves drug efficacy by controlling rate and time of release of drug. (bccresearch.com)
  • But then it flipped 13-4 in the other direction, voting that the drug does provide efficacy for a surrogate endpoint that is reasonably likely to predict a clinical benefit. (fool.com)
  • Combination drugs also have advantages over traditional medicines such as reduced need for drug application, improved efficacy and patient compliance. (sbwire.com)
  • If von Eschenbach has his way, FDA will be out of the business of approving new drugs based on efficacy, but will merely rubberstamp any drug that won't kill humans outright (see here )! (blogspot.com)
  • This report analyzes the worldwide markets for Anemia Drugs in US$ Million by the following segments: Short Acting ESAs (Erythropoiesis Stimulating Agents), and Long Acting ESAs (Erythropoiesis Stimulating Agents). (medindia.net)
  • Abbott's drugs business is, however, solely focused on providing affordable generic medicines in emerging markets, as the company does not sell medicine in the US, Europe or other developed markets, the spokesperson highlighted. (euractiv.com)
  • However, concentration was higher for narrower markets, such as for certain drugs in the same therapeutic class. (gao.gov)
  • McBride also argued that adopting final regulations without a blanket exclusion for convicted drug traffickers will attract unwanted attention from the federal Department of Justice, which earlier this year rescinded an Obama-era policy that essentially directed federal prosecutors to look the other way in states that have established legal marijuana markets. (wbjournal.com)
  • Asia, as for many other industries, represents one of the major markets for this industry in the near future. (sbwire.com)
  • We provide our services to all sizes of organizations and across all industry verticals and markets. (webnewswire.com)
  • Dr. Angell charges that the industry is "primarily a marketing machine to sell drugs of dubious benefits, using its wealth and power to co-opt every institution that might stand in its way, including the U.S. Congress, the Food and Drug Administration, academic medical centers and the medical profession itself. (counterpunch.org)
  • The Food and Drug Administration approved the pill in December. (npr.org)
  • Bloomberg recently reported drug approvals by the U.S. Food and Drug Administration reached a 15 year high in 2012. (yahoo.com)
  • The company's lead program, ADCETRIS, received accelerated approval from the U.S. Food and Drug Administration in August 2011 and approval with conditions from Health Canada in February 2013 for two indications. (yahoo.com)
  • Nevertheless, the U.S. Food and Drug Administration approved both of these drugs - with a deadly aftermath. (propublica.org)
  • The two drug reactions that are being studied, Stevens-Johnson and liver toxicity, are very common reasons for problems with drugs either being restricted, not being developed, not being approved or being pulled off the market," said Dr. Janet Woodcock, Deputy Commissioner and Chief Medical Officer at the U.S. Food and Drug Administration. (bio-medicine.org)
  • For more on drug safety and side effects, visit the U.S. Food and Drug Administration . (bio-medicine.org)
  • You may submit written comments and suggestions at any time for Agency consideration to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, rm. (fda.gov)
  • Drug reps typically keep physicians up to speed on pharmaceutical pipelines and medical research, something research shows doctors don't do enough on their own. (latimes.com)
  • He says the need to shield research and development networks from interconnected manufacturing and production networks is another feature of the industry. (computerweekly.com)
  • We need to get to the bottom of why we're seeing huge spikes in drug prices that seemingly have no relationship to research and development costs," said McCaskill in a statement. (denverpost.com)
  • The pharmaceutical industry spends far more on marketing and advertising to physicians and patients than what it spends on research and development. (counterpunch.org)
  • The Public Citizen Health Research Group published three books - Pills That Don't Work (1981), Over The Counter Pills That Don't Work (1983), and Worst Pills, Best Pills: A Consumer's Guide to Avoiding Drug-Induced Death or Illness (2005) - documenting hundreds of prescription and over-the-counter drugs that were not effective for their advertised purposes or had harmful side effects. (counterpunch.org)
  • The Johns Hopkins-MedImmune Scholars Program , believed to be a first-of-its-kind training program between a major university and a biopharmaceutical company in the United States, enables students to learn firsthand the process and challenges of drug discovery and development while still earning a traditional Ph.D. Research projects, managed by mentors at Johns Hopkins and MedImmune, may be conducted at both locations. (hopkinsmedicine.org)
  • The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). (openpr.com)
  • The Global Hyperphosphatemia Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Hyperphosphatemia Drug industry. (mynewsdesk.com)
  • This total service encompasses all of the European research services completed by the Pharmaceuticals, Biotechnology & Drug Discovery Technologies Group. (frost.com)
  • With the tens of millions it spends on lobbying a year, the organization is credited with being able to sway sentiment on Capitol Hill and with the public to help get its members what they want in everything from appropriations for basic research to new provisions in the Affordable Care Act that help patients afford prescription drugs - and add dollars to their own bottom lines. (washingtonpost.com)
  • Huidian Research estimates that the sales scale of cardiovascular drugs in China in 2014 will reach about CNY 22 billion, and the figure will be CNY 45 billion by 2018. (pitchengine.com)
  • Prescription drug prices would be controlled through the Department of Health and Human Services, and, McCaughey and Newsweek claim, would "certainly suppress research" that might benefit patients of incurable diseases and disorders. (historycommons.org)
  • The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. (pitchengine.com)
  • Order a copy of "Prostate Cancer Treatment Drugs Industry" research report at USD 1000 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=426034 . (pitchengine.com)
  • Drug industry spending for research and development increased from $82 billion in 2008 to $89 billion in 2014. (gao.gov)
  • From 2008 through 2014, worldwide company-reported R&D spending, most of which went to drug development (rather than research), increased slightly from $82 billion to $89 billion in 2015 dollars. (gao.gov)
  • During the same period, federal spending, which funded a greater amount of basic research relative to industry, remained stable at around $28 billion. (gao.gov)
  • Research GAO reviewed indicates that fewer competitors in the drug industry are associated with higher prices, particularly for generic drugs. (gao.gov)
  • Research also suggests that drug company mergers can have varied impacts on innovation as measured by R&D spending, patent approvals, and drug approvals. (gao.gov)
  • Instead of a regulator and a regulated industry, we now have a partnership," said Dr. Michael Carome, director of the health research group for the nonprofit advocacy organization Public Citizen, and a former U.S. Department of Health and Human Services official. (propublica.org)
  • More than half of the respondents reported receiving travel funding or honoraria, research support, or educational programming support from the drug industry. (ashp.org)
  • With this IBISWorld Industry Research Report on Antiviral Drug Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions. (ibisworld.com)
  • This research report categorizes the anti-Parkinson's drugs market by type. (bccresearch.com)
  • Highlights the controversy of discriminatory and unsafe research methods, discusses the drug industry, potential health effects on women, racist practices. (cwhn.ca)
  • Randall Mrsny, Ph.D., former Head of Genentech's Drug Delivery/Biology Lab, the Founder of Trinity Biosystems, the Founder and current Chief Scientific Officer of Unity Therapeutics, and Professor of Epithelial Biology at the University of Bath, UK, who will discuss his research in intracellular peptide drug delivery for epithelial-derived cancers. (prweb.com)
  • The immediate goal would be to develop a test that could identify who will have a problem with a drug before they get it," said Dr. Paul Watkins, director of the General Clinical Research Center at the University of North Carolina in Chapel Hill. (bio-medicine.org)
  • SAEC is one of several consortiums formed by the pharmaceutical industry to conduct basic research. (bio-medicine.org)
  • To sum it up, the report concludes with an all-inclusive research result on the industry chain of Drug Injection Device Sales Industry facilitating the market participants in making well-informed strategic decisions. (beforeitsnews.com)
  • Researchmoz added Most up-to-date research on "Optic Nerve Disorders Drug Development Pipeline Review, 2018" to its huge collection of research reports. (webnewswire.com)
  • We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. (webnewswire.com)
  • Included is an understanding of the strategy deployed for pricing drugs and new technologies as well as the market sizing exercise to identify where future research and development investments should be made. (coursera.org)
  • Center for Drug Evaluation and Research (U.S. (worldcat.org)
  • According to Market Research Future, the global drug device combination market is expected to register a clocking CAGR of 11.4% from 2018 to 2023. (marketwatch.com)
  • Additionally, other factors such as growing healthcare expenditure, raising awareness for the disease, and increasing research & development expenses made by the key players also drives the global drug device combination market. (marketwatch.com)
  • the PR campaign they've created is called "The Ethics, the Urgency and the Potential," and its premise is that it is "unethical not to use the drug. (slate.com)
  • These days, you are more likely to see "unethical" linked closely with the drug industry that during the time of its birth during the Civil War in the U.S. used "ethical" to distinguish its products from quack medicines. (blogspot.com)
  • Pharmaguy curates and provides insights into selected drug industry news and issues. (scoop.it)
  • Fake medicines often contain the wrong or toxic ingredients and pose a growing health threat worldwide, especially in poor countries where drugs are sold to treat conditions such as malaria, tuberculosis and HIV. (reuters.com)
  • The Association for Accessible Medicines, a generic industry trade group that filed the lawsuit, argues that the law is unconstitutional because it does not define price-gouging and amounts to intervention by an individual state in interstate commerce. (reuters.com)
  • Valeant is already under investigation by several members of Congress for its general business strategy, which involves buying smaller drug developers and then jacking up the prices of their medicines. (denverpost.com)
  • If Novartis wins, even older medicines could be subject to patenting again, and it will become much more difficult for us in future to provide medicines to our patients being treated for HIV, hepatitis and drug resistant TB. (law.com)
  • With the aged tendency of population in China and the increasing morbidity of chronic diseases which have to be treated with medicines for the rest of patients life, market scale of cardiovascular drugs is expanding. (pitchengine.com)
  • Drug rescue is also termed as rescue medicines. (openpr.com)
  • Drug which is given to counter or block the effect of other medicines are called as rescue medicines. (openpr.com)
  • In clinical trials, rescue medicines are given with a drug to control the alleviated symptoms of the study treatment or lack of disease efficiency. (openpr.com)
  • Ibuprofen or acetaminophen or drugs containing caffeine are the most common rescue medicines for migraine. (openpr.com)
  • Asia Pacific is the most progressive region for the drug rescue market due to increasing over-the-counter rescue medicines in the region. (openpr.com)
  • However, the increasing side effects of rescue medicines is likely to restrain the drug rescue market. (openpr.com)
  • As an industry we remain committed to working with all partners to continue to advance global health, improving access to medicines and the capacity and sustainability of healthcare systems," the EFPIA source concluded. (euractiv.com)
  • Between 2011 and 2015, the FDA reviewed new drug applications more than 60 days faster on average than did the European Medicines Agency. (propublica.org)
  • Reportlinker.com offers immediate download access to top market reports on the Allergy Drug Industry. (reportlinker.com)
  • The ease of portability of these machines, along with their lowering prices, is creating a higher demand in the global alcohol breathalyzer and drug testing equipment market. (sbwire.com)
  • China recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. (prweb.com)
  • These reports estimated the increase in the demand for drug devices for the related therapeutics significantly, enabling the drug device combination devices market to grow. (marketwatch.com)
  • PHARMACEUTICAL company executives are watching nervously as drug prices come under growing criticism in Congress and states that are scrimping to pay for Medicaid programs for the poor. (nytimes.com)
  • To get the discounts, Medicaid programs would have to accept all company products, exempting them from restrictions that currently exclude some expensive drugs. (nytimes.com)
  • So when a drug company gives money to bioethicists, it's a little like giving money to the poor. (slate.com)
  • If the drug company makes no effort to influence your work, is there anything wrong with taking their money? (slate.com)
  • Often, when a drug company is launching a new drug, it recruits a third party known as a Key Opinion Leader: an influential figure respected by his or her peers and often eagerly sought out by the press. (slate.com)
  • Mollie Shields-Uehling, chief executive of the US-based Safe Biopharma Association, says, "For each new drug application, there are between one million and six million pages of paper that have to be saved by the company and stored for the life of the drug, plus some significant amount of time after the drug comes off the market. (computerweekly.com)
  • A former hedge fund manager, Shkreli has become the public face of the pricing controversy, after his company raised the price of the anti-infection drug Daraprim by more than 5,000 percent. (denverpost.com)
  • Despite frequent exposure of misdeeds, the army of drug company lobbyists in Washington continues to gain political influence and rake in corporate welfare at the expense of taxpayers. (counterpunch.org)
  • The cause of competition was not helped when the drug company lobbyists used their campaign contributions and influence on Congress in 2003 to brazenly prohibit Uncle Sam from negotiating prices for the gigantic Medicare drug benefit program. (counterpunch.org)
  • The secret truth, however: Shkreli is far from the only drug company executive to set what critics say are exorbitant prices, and he certainly won't be the last. (washingtonpost.com)
  • The company and GlaxoSmithKline plc recently reported that the FDA has accepted its New Drug Application for ANORO ELLIPTA for patients with chronic obstructive pulmonary disease. (yahoo.com)
  • Many physicians are skeptical of statins' perceived benefits, particulalry because the study was funded by the drug company Astra-Zeneca, the maker of the statin drug used in the trial. (mercola.com)
  • A survey of clinical trials revealed that when a drug company funds a study , there is a 90 percent chance that the drug will be perceived as effective whereas a non-drug-company-funded study will show favorable results just 50 percent of the time. (mercola.com)
  • Line graph showing drug company profit margins nearing 20 percent. (gao.gov)
  • A survey of clinical practice guideline authors revealed that 87% had a financial relationship with at least one drug company. (ashp.org)
  • A subset of nearly 70 guideline authors offered their opinion of how the relationship with a drug company influenced the guideline-creation process. (ashp.org)
  • Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. (yahoo.com)
  • PITTSBURGH A news article published over the weekend calling generic drug maker Mylan's manufacturing into question has drawn a response from the company. (drugstorenews.com)
  • The archive contains documents about pharmaceutical industry clinical trials, publication of study results, pricing, marketing, relations with physicians and drug company involvement in continuing medical education. (wikipedia.org)
  • Ed Maggio, Ph.D., CEO of Aegis Therapeutics, a company focused on the commercialization of both advanced patented drug delivery, and protein stabilization technologies. (prweb.com)
  • It is one of the best-selling drugs in the world, generating billions of dollars of income every year, and yet, according to the journal, the drug company anticipated initial annual sales of just £100,000. (healthy.net)
  • This seems hard to believe, as it would have taken the drug company 500 years to recoup the licensing costs alone, and before any marketing costs. (healthy.net)
  • Frederick Stearns and Company was acquired by Sterling Drug in 1944. (blogspot.com)
  • Its chief executive, Richard Brook, resigned from the MHRA earlier this year over concerns about undue drug company influence on antidepressant licensing. (communitycare.co.uk)
  • Some are very opposed to using drug company money, others exploit it quite openly. (communitycare.co.uk)
  • There is a lot of merit to the Merck proposal,'' said a spokeswoman for another leading drug maker, who asked not to be identified. (nytimes.com)
  • Several Medicaid drug bills, including one that would strengthen Medi-Cal's leverage in bargaining for discounts and one supporting the Merck approach, have been introduced in the Legislature. (nytimes.com)
  • John L. Zabriskie, president of Merck Sharp & Dohme, Merck's drug-making unit, said that four states - Arkansas, Delaware, Utah and South Carolina - had indicated that they would accept Merck's offer. (nytimes.com)
  • For example, the drug Vioxx, sold by Merck &Co., Inc., as an anti-inflammatory drug, stayed on the market from 1999 to 2004 despite documented cardiovascular risks. (counterpunch.org)
  • That's O.K. for something like Merck 's (NYSE: MRK) anacetrapib, where the FDA is requiring clinical outcomes -- heart attacks, strokes, and the like -- rather than just demonstrating that the drug lowers bad cholesterol and raises the good kind. (fool.com)
  • By the way, the drug industry is required by law to fund a large portion of the FDA's drug review budget, which contributes to this weak regulatory oversight. (counterpunch.org)
  • These accomplishments could not have been achieved without the innovations of the biopharmaceutical industry and the dedication and skill of FDA's drug review staff. (yahoo.com)
  • This guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic. (fda.gov)
  • In an essay published by the Journal of the Royal Society of Medicine , health economists Professor Alan Maynard and Professor Karen Bloor describe an inflationary regulatory system that lacks accountability, is not evidence-based and subverts the efficiency of the technology appraisal work carried out by NICE, a target of pharmaceutical industry hostility since it was established in 1999. (medicalnewstoday.com)
  • Professionals, from industry service providers to end-user clients, will be in attendance to learn and discuss the very latest information on regulatory affairs, ethics, safety, and the business practices critical to their organization's outlook. (datia.org)
  • Once widely assailed for moving slowly, today the FDA reviews and approves drugs faster than any other regulatory agency in the world. (propublica.org)
  • Attendees will come away from this conference with a better understanding the clinical, regulatory, legal and commercial issues facing novel drug delivery technologies and their application in biologics and targeted therapies. (prweb.com)
  • Regulatory agencies rely on such industry funded studies for surveillance of drug safety. (bmj.com)
  • Has the pharmaceutical industry skilfully managed to achieve an unhealthy influence over European drug regulatory agencies? (scribd.com)
  • Design 42 placebo controlled studies of five selective serotonin reuptake inhibitors submitted to the Swedish drug regulatory authority as a basis for marketing approval for treating major depression were compared with the studies actually published (between 1983 and 1999). (bmj.com)
  • Forty two short term (4-8 weeks) placebo controlled clinical trials with the approved doses were submitted to the Swedish drug regulatory authority and formed the basis for the approvals. (bmj.com)
  • Members of the UK's drugs regulatory agency would be barred from having interests in the pharmaceutical industry under new rules proposed last week. (communitycare.co.uk)
  • It was definitely a wake-up call seeing how science can be done in so many different ways, and how MedImmune has so many resources to make science more fun and easy to do," says Majewska, who has career aspirations in the biopharmaceutical industry. (hopkinsmedicine.org)
  • Illicit drugs include illegal drugs (such as cannabis, opiates, and certain types of stimulants), pharmaceutical drugs (such as pain-killers and tranquillisers) when used for non-medical purposes, and other substances used inappropriately (such as inhalants). (wikipedia.org)
  • According to government and community organisations, the use and abuse, and the illegality, of illicit drugs is a social, health and legal issue that creates an annual illegal market estimated to be worth A$6.7 billion. (wikipedia.org)
  • In 1960's Sydney, the most high-profile use of illicit drugs was focused around the Kings Cross area, whose reputation as a "red light district" attracted members of various international armed forces on leave from the Indochina Wars. (wikipedia.org)
  • Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. (mynewsdesk.com)
  • According to EFPIA, the report completely fails to recognise the unique and important role played by the industry in delivering better health for millions of people across the world, transforming the outlook for patients living with serious, debilitating and sometimes fatal illnesses diseases like HIV, cancer, diabetes, cardiovascular disease, and hepatitis C. (euractiv.com)
  • Global Sports Medicine Market Report: 2015 Edition (http://www.marketreportsonline.com/425988.html) The global sports medicine market is a very dynamic sector that has made a mark in the healthcare industry in the last decade. (pitchengine.com)
  • The authors of clinical practice guidelines have extensive ties to the pharmaceutical industry, according to a recent report. (ashp.org)
  • The Pittsburgh Post-Gazette reported Sunday that workers at the company's Morgantown, W.Va., plant overrode drug quality controls required by the government by ignoring and deleting computer warnings of possible drug quality or equipment problems, based on a confidential internal report obtained by the newspaper's reporters that called it a "pervasive" problem. (drugstorenews.com)
  • The global drug delivery systems market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. (bccresearch.com)
  • Drug Injection Device Sales Industry Report is a tool to assist novice as well as seeded players in gaining astute business intelligence and make apt decisions based on it. (beforeitsnews.com)
  • Additionally, the Drug Injection Device Sales Industry report also discusses the data on deals (distributors) and buyers, providing a holistic insight into the supply chain and sales details of Drug Injection Device Sales Industry. (beforeitsnews.com)
  • The report analyses the entire production and supply chain of the industry and provides information as per different phases. (beforeitsnews.com)
  • No single adverse drug reaction report could be identified from any of the 558 post-marketing studies. (bmj.com)
  • The report is broadly divided into six parts and each part focus upon the industry overview, condition of the Onychomycosis (Tinea Unguium) Drug Industry, the investment feasibility as well as various policies and strategies. (beforeitsnews.com)
  • The report begins with the Onychomycosis (Tinea Unguium) Drug Industry Overview which is based upon by the classifications, specifications, modifications. (beforeitsnews.com)
  • In addition, the report brings the key players and their product development as well as the latest trend that should prove out to be quite beneficial for the new entrants to understand the industry in a better way. (beforeitsnews.com)
  • In order to prepare the report, all the important details, strategies and variables are studied so that all the useful information is blended together for the purpose of the study and understanding the major facts about the Global Onychomycosis (Tinea Unguium) Drug Industry. (beforeitsnews.com)
  • This report analyzes the Global market for Liver Cancer Drugs in US$ M. (bio-medicine.org)
  • The PBM's role is in part to leverage its negotiating clout to get the best drug prices on behalf of its diverse base of customers that include large employers as well as Medicare and Medicaid. (forbes.com)
  • While White House officials last week had said that the deal meant health reform legislation would not include a proposal to allow the federal government to negotiate Medicare drug prices, lawmakers said officials told them in a private meeting that there was no such agreement, the Times reports. (californiahealthline.org)
  • While AARP is "glad to see the brand-name pharmaceutical industry reaffirm its support for fixing the health care system and beginning to close the Medicare doughnut hole," the group "has no plans to stop there," LeaMond -- executive vice president of AARP -- writes in a Times letter to the editor. (californiahealthline.org)
  • AARP is "continuing to support measures that would close the doughnut hole over time," including provisions to increase generic drug presence in the market, import expensive drugs from other nations and allow the government to negotiate drug prices for Medicare beneficiaries, LeaMond writes (LeaMond, New York Times , 8/10). (californiahealthline.org)
  • He was participating in some industry clinical trials, but the route to helping patients wasn't direct enough. (sciencemag.org)
  • Nuplazid, a drug for hallucinations and delusions associated with Parkinson's disease, failed two clinical trials. (propublica.org)
  • But for orphan drugs with limited commercial potential, the ability to use surrogate endpoints is essential to getting the clinical trials done quickly and cheaply. (fool.com)
  • In clinical trials of drugs the role of the sponsor is especially important. (bmj.com)
  • The implications of this case reach far beyond India, and far beyond this particular cancer drug," said Leena Menghaney, from the aid group Doctors Without Borders. (law.com)
  • Professors Maynard and Bloor, of the Department of Health Sciences at the University of York, point to the evaluation of end-of-life products such as cancer drugs. (medicalnewstoday.com)
  • Also singled out for criticism is the Cancer Drugs Fund, which allocates £280 million per year to non-NICE approved cancer drugs on a case-by-case basis. (medicalnewstoday.com)
  • Professor Maynard said: "The Coalition government renewed and increased the Cancer Drugs Fund to serve two political goals: the garnering of votes from public interest groups and the subsidisation of the pharmaceutical industry. (medicalnewstoday.com)
  • Shkreli's flip-flop on the price of Daraprim, which is used to treat a life-threatening parasitic infection in patients with immune issues like HIV/AIDS and cancer, did little to improve his relationship with the rest of the industry. (washingtonpost.com)
  • NNT answers the question: How many people have to take a particular drug to avoid one incidence of a medical issue (such as a heart attack, or recurrence of cancer)? (mercola.com)
  • Europe has also rejected drugs for which the FDA accelerated approval, such as Folotyn, which treats a rare form of blood cancer. (propublica.org)
  • Should promising cancer drugs like Seattle Genetics ' (Nasdaq: SGEN) Adcetris not get accelerated approvals based on progression-free survival or response rate because the surrogate endpoints doesn't always correlate with overall survival? (fool.com)
  • Over the next 20 years systematic programmes of cancer risk assessment will be established and cancer-preventive drugs will be developed. (ddw-online.com)
  • The use of such pharmacodynamic (PD) endpoints will replace the current phase I dose escalation schedules by which the maximum tolerated dose of a cancer drug is determined (Table 1). (ddw-online.com)
  • It is conceivable that genetic indicator systems, introduced by direct injection into tumours, will yield information on both the effect of the drug locally and the response of cancer cells to it. (ddw-online.com)
  • Creating innovative partnerships between an increasingly consolidated and globalised industry and major cancer treatment centres is now essential to enhance the speed of drug development. (ddw-online.com)
  • Cancer drug development is entering a remarkable new phase. (ddw-online.com)
  • Although nearly all current anticancer drugs were discovered by serendipity1, the effectiveness of chemotherapy in treating cancer has been relatively disappointing. (ddw-online.com)
  • Not only are the delivery of proteins, peptides, insulin and vaccines being revolutionized by new drug delivery technologies, but novel therapeutic approaches, such as RNAi and targeted cancer therapies are being shaped by new drug delivery systems in development. (prweb.com)
  • Global Liver Cancer Drugs industry ( NEW YORK June a onClick var ss_g. (bio-medicine.org)
  • The passage of the Prescription Drug User Fee Act (PDUFA) played a major role in the sharp increase in approvals. (yahoo.com)
  • Pertaining to drug approvals, the total number of new drugs approved for marketing in the United States fluctuated between 2005 and 2016, ranging from 179 to 263 drug approvals annually. (gao.gov)
  • Novel drugs-innovative products that serve previously unmet medical need or help advance patient care-accounted for about 13 percent of all approvals each year. (gao.gov)
  • Biologics-drugs derived from living rather than chemical sources-and orphan drugs accounted for growing shares of drug approvals, reflecting market and policy incentives to invest in these areas, according to experts GAO interviewed. (gao.gov)
  • While the FDA over the past three decades has implemented at least four major routes to faster approvals - the current commissioner, Dr. Scott Gottlieb, is easing even more drugs' path to market. (propublica.org)
  • Because the event is hosted by DATIA, the leading association involved in shaping and developing the industry for over 23 years, attendees are assured that the speakers, seminars, educational content, and networking events will be highly rewarding. (datia.org)
  • For those new to drug and alcohol testing or looking for a primer, DATIA recommends taking the Ins & Outs of Drug & Alcohol Testing online course prior to taking this course. (datia.org)
  • It may even increase costs,'' said Gerald J. Mossinghof, the association's president, adding that patients whose drugs were restricted often required additional care from doctors in hospitals. (nytimes.com)
  • It was on the list of the top 10 drugs in the US on sci.med, and it has been shown to cause MORE heart attacks in hypertensive patients, than no treatment at all. (bio.net)
  • The drug, which Turing acquired in August, is the only U.S.-approved treatment for a deadly parasitic infection that can affect pregnant women and patients with HIV. (denverpost.com)
  • Together, we will provide our clients, their patients, and their prescribers with innovative services that meet the demands of a dynamic industry. (forbes.com)
  • But challenges remain, including who will pay for the drugs and how they will be distributed to patients in remote areas. (redorbit.com)
  • Other so-called "break-through" drugs are costing patients over $100,000 each a year and driving frantic health insurers and Medicaid managers up the wall. (counterpunch.org)
  • Eventually we could scale up this model from a molecular level to a virtual patient, and simulate the effects of these drugs in a population of virtual patients to run a virtual clinical trial. (hopkinsmedicine.org)
  • However, many industry insiders say these changes are opening up unique opportunities for researchers who focus on translating basic science into real-world cures and are eager to explore the molecular mechanisms of disease, test hypotheses, and do work that benefits patients. (sciencemag.org)
  • The opportunity to directly help patients is a powerful attraction to the pharmaceutical industry for some scientists, especially scientists with medical training. (sciencemag.org)
  • The BMJ has evidence that unlicensed employees from several Indian drug firms and from the Indian arms of Abbott, Bayer, GlaxoSmithKline, Roche, and Sanofi have tested patients at health camps. (eurekalert.org)
  • This kind of behavior can actually lead to harm to patients -- overdiagnosis, misclassification [of healthy people as sick], iatrogenic harm of drugs," Glyn Elwyn, a primary care clinician-researcher at The Dartmouth Center for Health Care Delivery Science in Hanover, New Hampshire, USA, told The BMJ. (eurekalert.org)
  • This summer, a group of prominent cystic fibrosis doctors and their patients were up in arms over the pricing of a drug called Orkambi, which Vertex Pharmaceuticals set at $259,000 per year wholesale. (washingtonpost.com)
  • Accepting this kind of data as a scientific study to actually help patients seems a joke to me in view of the decades-long (possibly centuries) history of knowing these drugs are dangerous, addictive and cause personality changes. (smokymountainnews.com)
  • Patients on Uloric, a gout drug, suffered more heart attacks, strokes and heart failure in two out of three trials than did their counterparts on standard or no medication. (propublica.org)
  • Uloric's manufacturer reported last November that patients on the drug were 34 percent more likely to die from heart disease than people taking an alternative gout medication. (propublica.org)
  • And since the FDA fast-tracked approval of Nuplazid and it went on the market in 2016 at a price of $24,000 a year, there have been 6,800 reports of adverse events for patients on the drug, including 887 deaths as of this past March 31. (propublica.org)
  • As patients (or their insurers) shell out tens or hundreds of thousands of dollars for unproven drugs, manufacturers reap a windfall. (propublica.org)
  • President Trump has encouraged Gottlieb to give patients faster access to drugs. (propublica.org)
  • A session on the evolution of the community pharmacist to specialty pharmacist sought to help attendees learn the educational requirements necessary to best serve specialty patients and other important information and included Community Specialty Pharmacy Network VP industry relations Nick Calla, National Association of Specialty Pharmacy founder and CEO Gary Cohen and URAC senior manager for product development Terri Smith Moore. (drugstorenews.com)
  • Should Vertex Pharmaceuticals (Nasdaq: VRTX) , Gilead Sciences (Nasdaq: GILD) , and others have to prove that their hepatitis C drugs cause patients to live longer after they're rid from the virus? (fool.com)
  • Combination drugs have the benefit of going well as first line treatment options for patients with high intraocular pressure. (sbwire.com)
  • The findings of the consortium could have an impact on improving the ability of patients to safely use existing drugs, Holden added. (bio-medicine.org)
  • Main outcome measures Descriptive statistics of post-marketing studies, including the products under study, intended number of patients, intended number of participating physicians, proposed remunerations, study plan and protocol, and availability of associated scientific publications and reports on adverse drug reactions. (bmj.com)
  • In the future, the dynamics of the lucrative moderate to severe UC market will shift greatly from the historical strategy of developing biologic drugs, towards small molecule oral drugs. (medgadget.com)
  • Although over 50 small-molecule drugs have entered clinical development, only two compounds have received a licence: maraviroc, which targets CCR5 for the treatment of HIV infection, and plerixafor, which targets CXCR4 to treat lymphoma and multiple myeloma. (diamond.ac.uk)
  • Well, considering that any institution which developed and marketed a drug would immediately become part of the pharmeceutical industry by definition, your request for a list is rather self-serving. (bio.net)
  • however, as PEG-rhGHbelongs to national new First-in-Class drugs, a phase IV clinical trial is a must, and mass production is expected to begin in 2016. (prweb.com)
  • WASHINGTON, Nov. 30, 2016 - As he heads out the door, President Obama will put in place two key parts of his administration's strategy to restrict the use of antibiotics in agriculture, part of a broader strategy for fighting drug-resistant germs. (agri-pulse.com)
  • On the other hand, the advanced wound care products segment is also sub-alienated into antibiotic wound care, bone graft substitutes, antibiotic bone cements, drug eluting stents, and photodynamic therapy. (marketwatch.com)
  • Avista's commitment to the healthcare industry makes them the ideal partner as we continue to improve patient care," Lindsay said. (forbes.com)
  • They're looking at the revenues from the more recent drugs in the pipeline (approved in the last five years) and comparing that to each company's total R&D spending. (sciencemag.org)
  • Former Rep. Patrick Kennedy (D-R.I.) says that lobbyists pushing for the legalization of medical marijuana are trying to sell the public on a "Trojan horse" - making the drug seem more normalized and acceptable in society, though it still has dangerous impacts on minors. (yahoo.com)
  • The pharmaceutical industry has authorized its lobbyists to spend about $150 million on television advertisements supporting health reform, people close to the issue said on Saturday, the New York Times reports. (californiahealthline.org)
  • John McCain Fought To Allow The Importation Of Cheaper Drugs Which Was "Adamantly Opposed By Industry Lobbyists. (edrugsearch.com)
  • McCain said he wanted the government to be able to negotiate lower drug prices and import cheaper drugs from Canada, both ideas that were adamantly opposed by industry lobbyists, and which ultimately failed. (edrugsearch.com)
  • Of the major anticonvulsant drugs currently marketed, Lyrica (pregabalin), Neurontin (gabapentin), Topamax (topiramate), Depakote (divalproex), and Carbatrol/Tegretol (carbamazepine) are indicated for management of various types of pain. (openpr.com)
  • Frost & Sullivan offers total market subscriptions for each of the major industry sectors. (frost.com)
  • A major portion of the global alcohol breathalyzer and drug testing equipment market finds use in the field of law enforcement and highway safety administrations. (sbwire.com)
  • For the ease of understanding, the global market of ophthalmic drugs can be generally segmented in three major divisions - drugs according to treatments, drugs according to types and the major geographic regions of importance for this industry. (sbwire.com)
  • Taylor sees little chance that the industry will reverse these major initiatives. (agri-pulse.com)
  • It properly analyzes the world's major regions market conditions and helps the established players as well as the new entrants with a comprehensive insight of the current situation in the Onychomycosis (Tinea Unguium) Drug industry. (beforeitsnews.com)
  • Global drug device combination market, in the Americas, is leading owing to the rising prevalence of cardiovascular diseases and the presence of major market players within the region. (marketwatch.com)
  • American troops stationed in major Australian cities such as Sydney provided access to drugs like heroin. (wikipedia.org)
  • The public health doesn't stand a chance in this fight, because we're up against money that is going to continue to grow as this industry spreads," Kennedy concedes, likening marijuana proponents to the big tobacco industry. (yahoo.com)
  • In Rhode Island, where the district he represented in Congress is located, drug overdoses are a public health crisis . (yahoo.com)
  • Given the rapidly changing industry dynamics, some observers believe Express Scripts will be forced to sell to a larger player, especially if the now month-old rumor of CVS Health merging with Aetna becomes a reality. (forbes.com)
  • The decision to move to industry was born of a desire to work someplace "where the focus was still very much on the science but there was still a likelihood that my work will have an impact on human health within my lifetime," he says. (sciencemag.org)
  • Alcohol and drug abuse creates significant safety and health hazards and can result in decreased productivity and poor employee morale. (datia.org)
  • However, Federal agencies conducting drug testing must follow standardized procedures established by the Substance Abuse and Mental Health Services Administration (SAMHSA), part of the U.S. Department of Health and Human Services (DHHS). (datia.org)
  • The most common method of drug testing, urinalysis, can be done at the workplace (at a health unit, for example), a doctor's office or any other site selected by the employer. (datia.org)
  • The Centers for Disease Control, the National Institute of Health and the National Institute of Mental Health are calling deaths from drug overdoses the "modern epidemic," and indeed it is. (smokymountainnews.com)
  • Retail prescription drug expenditures were estimated to account for about 12 percent of total personal health care service spending in the United States in 2015, up from about 7 percent through the 1990s. (gao.gov)
  • That relationship has tilted the agency away from a public health perspective to an industry friendly perspective. (propublica.org)
  • The only thing voluntary about it was the alignment around the goal that the industry and producers both realized needed to be achieved, which was that you've got to move past this ancient, anti-public health technology to a place that is better, that consumers will accept. (agri-pulse.com)
  • According to the Times , the pharmaceutical industry so far has contributed millions of dollars to advertising campaigns for health reform through advocacy groups like Families USA and Healthy Economies Now. (californiahealthline.org)
  • Later on Friday, Linda Douglass, communications director for the White House Office of Health Reform, said the issue of drug price negotiation was not discussed with the drug industry. (californiahealthline.org)
  • The cost of pharmaceuticals is a "significant factor in health care inflation," the editorial says, concluding that Congress "should not be deterred from demanding further concessions from the pharmaceutical industry" ( San Francisco Chronicle , 8/10). (californiahealthline.org)
  • At a health committee hearing last week, a representative from the Royal College of Psychiatrists said it was embarrassed at the revelation that it had taken £130,000 from the pharmaceutical industry for its Defeat Depression campaign. (communitycare.co.uk)
  • This question is particularly salient to the US pharmaceutical industry, which is the largest private contributor to US medical R&D, and has agreed to provide up to $80 billion in cost savings over ten years in connection with comprehensive health reform. (theincidentaleconomist.com)
  • The second class of opium users included doctors, nurses and other health professionals, who used the drug as a strategy for coping with the stress of their work. (wikipedia.org)
  • Desmond Manderson, an expert on the history of Australian drug policy, has asserted that from this time forward, Australia's drug policies have been more dictated by international relations and a political need for moral panic than any concern for health and welfare (Manderson, 1993). (wikipedia.org)
  • Hence, the strong British influence on Australia's drug policies waned, and Australia's illicit drug policies shifted from a health and social focus to an increased focus on law enforcement and criminal justice. (wikipedia.org)
  • All of those issues affect drug prices, but you have to have something to sell before you can talk about its price. (theatlantic.com)
  • Reuters) - As U.S. consumer outrage grows over prescription drug prices, state authorities and patient advocates in Maryland are preparing to enforce the nation's first law designed to punish drugmaker price-gouging. (reuters.com)
  • We're already paying very high prices for some of the new drugs that are patented in India," said Petros Isaakidis, an epidemiologist with Doctors Without Borders. (law.com)
  • The drug industry goes beyond crony capitalism when it then charges Americans the highest drug prices in the world. (counterpunch.org)
  • Katharine Greider points out in her book The Big Fix: How the Pharmaceutical Industry Rips off American Consumers that, "Other countries move to control prices and sharply limit advertising. (counterpunch.org)
  • Or does government tacitly wish to tax the NHS with high pharmaceutical prices of sometimes inefficient drugs and, in so doing, increase the wealth of industry? (medicalnewstoday.com)
  • Much of this increase is due to expensive brand-name drugs, but the prices of some generics have also gone up. (gao.gov)
  • Teams developing the drug must work hand-in-hand with teams developing the delivery device, ultimately agreeing on the proper combination of elements to best serve the intended patient pool - a process that weaves together decisions concerning biocompatibility, container size and shape, delivery mechanism, human factors engineering, and countless other elements. (pharmaceuticalonline.com)
  • It's an orphan drug to treat Transthyretin Familial Amyloid Polyneuropathy, which affects an estimated 2,500 to 3,000 Americans, with a total 8,000 to 10,000 estimated incidence worldwide. (fool.com)
  • As a result, hundreds of new rare-disease treatments have entered the market over the past few decades, and orphan drug development has become a highly profitable industry. (the-scientist.com)
  • In this Thursday, Oct. 1, 2015, file photo, carrying an image of Turing Pharmaceuticals CEO Martin Shkreli in a makeshift cat litter pan, AIDS activists and others are asked to leave the lobby of 1177 6th Ave. in New York, during a protest highlighting pharmaceutical drug pricing. (denverpost.com)
  • Turing Pharmaceuticals was a member of BIO for a brief period of time and is currently no longer a member," a spokesman for the organization told FierceBiotech , a daily newsletter for the industry. (washingtonpost.com)